Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
dimiracetam | [no description available] | medium | 1 | 0 | | |
scopolamine hydrobromide | [no description available] | medium | 17 | 0 | | |
scopolamine hydrobromide | [no description available] | medium | 17 | 1 | | |
aniracetam | [no description available] | medium | 11 | 0 | N-acylpyrrolidine; pyrrolidin-2-ones | |
piracetam | [no description available] | medium | 31 | 0 | organonitrogen compound; organooxygen compound | |
piracetam | [no description available] | medium | 31 | 2 | organonitrogen compound; organooxygen compound | |
gamma-aminobutyric acid | [no description available] | medium | 2 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
acetamide | [no description available] | medium | 1 | 0 | acetamides; carboximidic acid; monocarboxylic acid amide; N-acylammonia | |
quinacrine | [no description available] | medium | 4 | 0 | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
catechol | [no description available] | medium | 1 | 0 | catechols | allelochemical; genotoxin; plant metabolite |
taxifolin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavanones; 4'-hydroxyflavanones; dihydroflavonols; pentahydroxyflavanone; secondary alpha-hydroxy ketone | |
phosphonoacetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid; phosphonic acids | antiviral agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor |
3,4-dihydroxyphenylacetic acid | [no description available] | medium | 1 | 0 | catechols; dihydroxyphenylacetic acid | human metabolite |
aminocaproic acid | [no description available] | medium | 2 | 0 | amino acid zwitterion; epsilon-amino acid; omega-amino fatty acid | antifibrinolytic drug; hematologic agent; metabolite |
diacetyl | [no description available] | medium | 1 | 0 | alpha-diketone | Escherichia coli metabolite; Saccharomyces cerevisiae metabolite |
hydroquinone | [no description available] | medium | 1 | 0 | benzenediol; hydroquinones | antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent |
melatonin | [no description available] | medium | 1 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
n-acetylserotonin | [no description available] | medium | 1 | 0 | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist |
pyrazinamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; N-acylammonia; pyrazines | antitubercular agent; prodrug |
quinolinic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist |
taurine | [no description available] | medium | 1 | 0 | amino sulfonic acid; zwitterion | antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite |
2-amino-5-phosphonovalerate | [no description available] | medium | 5 | 0 | non-proteinogenic alpha-amino acid | NMDA receptor antagonist |
alpha-methyl-4-carboxyphenylglycine | [no description available] | medium | 1 | 0 | | |
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | [no description available] | medium | 1 | 0 | | |
1-hydroxy-3-amino-2-pyrrolidone | [no description available] | medium | 1 | 0 | | |
ibotenic acid | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid | neurotoxin |
n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane | [no description available] | medium | 1 | 0 | | |
sk&f-38393 | [no description available] | medium | 1 | 0 | benzazepine; catechols; secondary amino compound | |
vanilmandelic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid; aromatic ether; phenols | human metabolite |
1,10-diaminodecane | [no description available] | medium | 1 | 0 | | |
1,3-diethyl-8-phenylxanthine | [no description available] | medium | 1 | 0 | | |
1,3-dipropyl-8-cyclopentylxanthine | [no description available] | medium | 3 | 0 | oxopurine | adenosine A1 receptor antagonist; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
1,3-dipropyl-8-(4-sulfophenyl)xanthine | [no description available] | medium | 1 | 0 | | |
1,5-dihydroxyisoquinoline | [no description available] | medium | 1 | 0 | isoquinolinol | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
pk 11195 | [no description available] | medium | 1 | 0 | aromatic amide; isoquinolines; monocarboxylic acid amide; monochlorobenzenes | antineoplastic agent |
1-(2-trifluoromethylphenyl)imidazole | [no description available] | medium | 1 | 0 | imidazoles | |
1-aminobenzotriazole | [no description available] | medium | 1 | 0 | | |
1-methylimidazole | [no description available] | medium | 1 | 0 | imidazoles | |
edelfosine | [no description available] | medium | 1 | 0 | glycerophosphocholine | |
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | [no description available] | medium | 1 | 0 | oxadiazoloquinoxaline | EC 4.6.1.2 (guanylate cyclase) inhibitor |
2,2'-dipyridyl | [no description available] | medium | 1 | 0 | bipyridine | chelator; ferroptosis inhibitor |
2-hydroxysaclofen | [no description available] | medium | 1 | 0 | organochlorine compound | |
3,4-dichloroisocoumarin | [no description available] | medium | 1 | 0 | isocoumarins; organochlorine compound | geroprotector; serine protease inhibitor |
phaclofen | [no description available] | medium | 1 | 0 | organophosphate oxoanion; zwitterion | |
3-aminobenzamide | [no description available] | medium | 1 | 0 | benzamides; substituted aniline | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
3-bromo-7-nitroindazole | [no description available] | medium | 1 | 0 | | |
enprofylline | [no description available] | medium | 2 | 0 | oxopurine | anti-arrhythmia drug; anti-asthmatic drug; bronchodilator agent; non-steroidal anti-inflammatory drug |
3-nitropropionic acid | [no description available] | medium | 1 | 0 | C-nitro compound | antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin |
4-amino-1,8-naphthalimide | [no description available] | medium | 1 | 0 | benzoisoquinoline; dicarboximide | |
4-aminopyridine | [no description available] | medium | 2 | 0 | aminopyridine; aromatic amine | avicide; orphan drug; potassium channel blocker |
homovanillic acid | [no description available] | medium | 1 | 0 | guaiacols; monocarboxylic acid | human metabolite; mouse metabolite |
4-hydroxybenzoic acid hydrazide | [no description available] | medium | 1 | 0 | carbohydrazide; phenols | |
4-phenyl-3-furoxancarbonitrile | [no description available] | medium | 1 | 0 | 1,2,5-oxadiazole; benzenes; N-oxide; nitrile | geroprotector; nitric oxide donor; platelet aggregation inhibitor; soluble guanylate cyclase activator; vasodilator agent |
5,5-dimethyl-1-pyrroline-1-oxide | [no description available] | medium | 1 | 0 | 1-pyrroline nitrones | neuroprotective agent; spin trapping reagent |
phenytoin | [no description available] | medium | 3 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
5,7-dichlorokynurenic acid | [no description available] | medium | 1 | 0 | quinolines | |
5-(n,n-hexamethylene)amiloride | [no description available] | medium | 1 | 0 | aromatic amine; azepanes; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines | antineoplastic agent; apoptosis inducer; odorant receptor antagonist; sodium channel blocker |
ethylisopropylamiloride | [no description available] | medium | 1 | 0 | aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound | anti-arrhythmia drug; neuroprotective agent; sodium channel blocker |
5-fluoroindole-2-carboxylic acid | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
hydroxyindoleacetic acid | [no description available] | medium | 1 | 0 | indole-3-acetic acids | drug metabolite; human metabolite; mouse metabolite |
phenanthridone | [no description available] | medium | 1 | 0 | lactam; phenanthridines | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; immunosuppressive agent; mutagen |
6-chloromelatonin | [no description available] | medium | 1 | 0 | acetamides | |
6-hydroxymelatonin | [no description available] | medium | 1 | 0 | acetamides; tryptamines | metabolite; mouse metabolite |
6-methoxytryptoline | [no description available] | medium | 1 | 0 | | |
6-nitroso-1,2-benzopyrone | [no description available] | medium | 1 | 0 | | |
7-chlorokynurenic acid | [no description available] | medium | 1 | 0 | organochlorine compound; quinolinemonocarboxylic acid | neuroprotective agent; NMDA receptor antagonist |
7-nitroindazole | [no description available] | medium | 1 | 0 | | |
8-(4-sulfophenyl)theophylline | [no description available] | medium | 1 | 0 | | |
8-cyclopentyl-1,3-dimethylxanthine | [no description available] | medium | 1 | 0 | oxopurine | |
8-phenyltheophylline | [no description available] | medium | 1 | 0 | | |
acetazolamide | [no description available] | medium | 2 | 0 | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
acetohexamide | [no description available] | medium | 1 | 0 | acetophenones; N-sulfonylurea | hypoglycemic agent; insulin secretagogue |
ag 127 | [no description available] | medium | 1 | 0 | nitrophenol | |
rtki cpd | [no description available] | medium | 1 | 0 | aromatic ether; monochlorobenzenes; quinazolines | antineoplastic agent; antiviral agent; epidermal growth factor receptor antagonist; geroprotector |
tyrphostin a23 | [no description available] | medium | 1 | 0 | catechols | |
tyrphostin 25 | [no description available] | medium | 1 | 0 | benzenetriol | |
tyrphostin a1 | [no description available] | medium | 1 | 0 | methoxybenzenes | geroprotector |
1-aminoindan-1,5-dicarboxylic acid | [no description available] | medium | 3 | 0 | | |
albuterol | [no description available] | medium | 3 | 0 | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic |
alpha-methyltyrosine methyl ester | [no description available] | medium | 1 | 0 | | |
altretamine | [no description available] | medium | 1 | 0 | triamino-1,3,5-triazine | |
amfonelic acid | [no description available] | medium | 1 | 0 | | |
amifostine anhydrous | [no description available] | medium | 1 | 0 | diamine; organic thiophosphate | antioxidant; prodrug; radiation protective agent |
theophylline | [no description available] | medium | 3 | 0 | dimethylxanthine | adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent |
amoxapine | [no description available] | medium | 1 | 0 | dibenzooxazepine | adrenergic uptake inhibitor; antidepressant; dopaminergic antagonist; geroprotector; serotonin uptake inhibitor |
2-amino-4-phosphonobutyric acid | [no description available] | medium | 1 | 0 | | |
aspirin | [no description available] | medium | 2 | 0 | benzoic acids; phenyl acetates; salicylates | anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent |
atenolol | [no description available] | medium | 4 | 0 | ethanolamines; monocarboxylic acid amide; propanolamine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic |
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate | [no description available] | medium | 1 | 0 | alpha-amino acid | |
aurintricarboxylic acid | [no description available] | medium | 1 | 0 | monohydroxybenzoic acid; quinomethanes; tricarboxylic acid | fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist |
azathioprine | [no description available] | medium | 1 | 0 | aryl sulfide; C-nitro compound; imidazoles; thiopurine | antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug |
azelaic acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | antibacterial agent; antineoplastic agent; dermatologic drug; plant metabolite |
baclofen | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid; monochlorobenzenes; primary amino compound | central nervous system depressant; GABA agonist; muscle relaxant |
bay-k-8644 | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester | |
benzamide | [no description available] | medium | 1 | 0 | benzamides | |
bepridil | [no description available] | medium | 1 | 0 | pyrrolidines; tertiary amine | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
bml 190 | [no description available] | medium | 1 | 0 | N-acylindole | |
brimonidine | [no description available] | medium | 1 | 0 | imidazoles; quinoxaline derivative; secondary amine | adrenergic agonist; alpha-adrenergic agonist; antihypertensive agent |
bumetanide | [no description available] | medium | 3 | 0 | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
caffeine | [no description available] | medium | 4 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
carbamazepine | [no description available] | medium | 3 | 0 | dibenzoazepine; ureas | analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic |
carbetapentane | [no description available] | medium | 1 | 0 | benzenes | |
carisoprodol | [no description available] | medium | 1 | 0 | carbamate ester | muscle relaxant |
carmustine | [no description available] | medium | 2 | 0 | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent |
cgs 12066 | [no description available] | medium | 1 | 0 | N-arylpiperazine; organofluorine compound; pyrroloquinoxaline | serotonergic agonist |
cgs 15943 | [no description available] | medium | 1 | 0 | aromatic amine; biaryl; furans; organochlorine compound; primary amino compound; quinazolines; triazoloquinazoline | adenosine A1 receptor antagonist; adenosine A2A receptor antagonist; antineoplastic agent; central nervous system stimulant |
chlorambucil | [no description available] | medium | 3 | 0 | aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent |
chlormezanone | [no description available] | medium | 1 | 0 | 1,3-thiazine; lactam; monochlorobenzenes; sulfone | antipsychotic agent; anxiolytic drug; muscle relaxant |
chlorothiazide | [no description available] | medium | 1 | 0 | benzothiadiazine | antihypertensive agent; diuretic |
chlorpropamide | [no description available] | medium | 3 | 0 | monochlorobenzenes; N-sulfonylurea | hypoglycemic agent; insulin secretagogue |
chlorzoxazone | [no description available] | medium | 1 | 0 | 1,3-benzoxazoles; heteroaryl hydroxy compound; organochlorine compound | muscle relaxant; sedative |
cilostamide | [no description available] | medium | 1 | 0 | quinolines | |
cilostazol | [no description available] | medium | 1 | 0 | lactam; tetrazoles | anticoagulant; bronchodilator agent; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; fibrin modulating drug; neuroprotective agent; platelet aggregation inhibitor; vasodilator agent |
cimetidine | [no description available] | medium | 3 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
cinoxacin | [no description available] | medium | 1 | 0 | cinnolines; oxacycle; oxo carboxylic acid | antibacterial drug; antiinfective agent |
ciprofibrate | [no description available] | medium | 1 | 0 | cyclopropanes; monocarboxylic acid; organochlorine compound | antilipemic drug |
clofibrate | [no description available] | medium | 1 | 0 | aromatic ether; ethyl ester; monochlorobenzenes | anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist |
clotrimazole | [no description available] | medium | 3 | 0 | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic |
cx546 | [no description available] | medium | 1 | 0 | | |
cyclothiazide | [no description available] | medium | 1 | 0 | benzothiadiazine | antihypertensive agent; diuretic |
dephostatin | [no description available] | medium | 1 | 0 | | |
nonivamide | [no description available] | medium | 1 | 0 | capsaicinoid; phenols | lachrymator |
r 59022 | [no description available] | medium | 1 | 0 | diarylmethane | |
diazoxide | [no description available] | medium | 3 | 0 | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent |
pentetic acid | [no description available] | medium | 1 | 0 | pentacarboxylic acid | copper chelator |
diphenyleneiodonium | [no description available] | medium | 1 | 0 | organic cation | |
dipyridamole | [no description available] | medium | 1 | 0 | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
disopyramide | [no description available] | medium | 3 | 0 | monocarboxylic acid amide; pyridines; tertiary amino compound | anti-arrhythmia drug |
disulfiram | [no description available] | medium | 1 | 0 | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor |
2-amino-7-phosphonoheptanoic acid | [no description available] | medium | 3 | 0 | | |
thiorphan | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
2,3-dimethoxy-1,4-naphthoquinone | [no description available] | medium | 1 | 0 | 1,4-naphthoquinones | |
domperidone | [no description available] | medium | 3 | 0 | benzimidazoles; heteroarylpiperidine | antiemetic; dopaminergic antagonist |
droperidol | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; organofluorine compound | anaesthesia adjuvant; antiemetic; dopaminergic antagonist; first generation antipsychotic |
ebselen | [no description available] | medium | 1 | 0 | benzoselenazole | anti-inflammatory drug; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 3.5.4.1 (cytosine deaminase) inhibitor; EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor; enzyme mimic; ferroptosis inhibitor; genotoxin; hepatoprotective agent; neuroprotective agent; radical scavenger |
ellipticine | [no description available] | medium | 1 | 0 | indole alkaloid; organic heterotetracyclic compound; organonitrogen heterocyclic compound; polycyclic heteroarene | antineoplastic agent; plant metabolite |
emodin | [no description available] | medium | 1 | 0 | trihydroxyanthraquinone | antineoplastic agent; laxative; plant metabolite; tyrosine kinase inhibitor |
ethosuximide | [no description available] | medium | 1 | 0 | dicarboximide; pyrrolidinone | anticonvulsant; geroprotector; T-type calcium channel blocker |
etodolac | [no description available] | medium | 1 | 0 | monocarboxylic acid; organic heterotricyclic compound | antipyretic; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
felbamate | [no description available] | medium | 1 | 0 | carbamate ester | anticonvulsant; neuroprotective agent |
felodipine | [no description available] | medium | 3 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
fenofibrate | [no description available] | medium | 1 | 0 | aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic |
flumazenil | [no description available] | medium | 3 | 0 | ethyl ester; imidazobenzodiazepine; organofluorine compound | antidote to benzodiazepine poisoning; GABA antagonist |
fluorouracil | [no description available] | medium | 2 | 0 | nucleobase analogue; organofluorine compound | antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic |
fluspirilene | [no description available] | medium | 1 | 0 | diarylmethane | |
flutamide | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; monocarboxylic acid amide | androgen antagonist; antineoplastic agent |
formoterol fumarate | [no description available] | medium | 1 | 0 | formamides; phenols; phenylethanolamines; secondary alcohol; secondary amino compound | |
fpl 64176 | [no description available] | medium | 1 | 0 | carboxylic ester; pyrroles | calcium channel agonist |
furafylline | [no description available] | medium | 1 | 0 | oxopurine | |
furosemide | [no description available] | medium | 3 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
fusaric acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
gabapentin | [no description available] | medium | 3 | 0 | gamma-amino acid | anticonvulsant; calcium channel blocker; environmental contaminant; xenobiotic |
4-amino-5-hexynoic acid | [no description available] | medium | 1 | 0 | | |
glipizide | [no description available] | medium | 3 | 0 | aromatic amide; monocarboxylic acid amide; N-sulfonylurea; pyrazines | EC 2.7.1.33 (pantothenate kinase) inhibitor; hypoglycemic agent; insulin secretagogue |
glyburide | [no description available] | medium | 3 | 0 | monochlorobenzenes; N-sulfonylurea | anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent |
1-(5-isoquinolinesulfonyl)piperazine | [no description available] | medium | 1 | 0 | isoquinolines | |
haloperidol | [no description available] | medium | 5 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
hemicholinium 3 | [no description available] | medium | 1 | 0 | morpholines | |
4-fluorohexahydrosiladifenidol | [no description available] | medium | 1 | 0 | | |
hydrochlorothiazide | [no description available] | medium | 1 | 0 | benzothiadiazine; organochlorine compound; sulfonamide | antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
hydroxyurea | [no description available] | medium | 3 | 0 | one-carbon compound; ureas | antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent |
ibudilast | [no description available] | medium | 1 | 0 | pyrazolopyridine | |
ibuprofen | [no description available] | medium | 3 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic |
ic 261 | [no description available] | medium | 1 | 0 | indoles | |
ifenprodil | [no description available] | medium | 1 | 0 | piperidines | |
indirubin-3'-monoxime | [no description available] | medium | 1 | 0 | | |
indomethacin | [no description available] | medium | 3 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
iodoacetamide | [no description available] | medium | 1 | 0 | | |
1-methyl-3-isobutylxanthine | [no description available] | medium | 1 | 0 | 3-isobutyl-1-methylxanthine | |
4-piperidinecarboxylic acid | [no description available] | medium | 1 | 0 | | |
4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline | [no description available] | medium | 1 | 0 | | |
jl 18 | [no description available] | medium | 1 | 0 | | |
nsc 664704 | [no description available] | medium | 1 | 0 | indolobenzazepine; lactam; organobromine compound | cardioprotective agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; geroprotector |
ketoconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
ketoprofen | [no description available] | medium | 3 | 0 | benzophenones; oxo monocarboxylic acid | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic |
kynurenic acid | [no description available] | medium | 2 | 0 | monohydroxyquinoline; quinolinemonocarboxylic acid | G-protein-coupled receptor agonist; human metabolite; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist; Saccharomyces cerevisiae metabolite |
2-amino-3-phosphonopropionic acid | [no description available] | medium | 1 | 0 | alanine derivative; non-proteinogenic alpha-amino acid; phosphonic acids | human metabolite; metabotropic glutamate receptor antagonist |
lamotrigine | [no description available] | medium | 2 | 0 | 1,2,4-triazines; dichlorobenzene; primary arylamine | anticonvulsant; antidepressant; antimanic drug; calcium channel blocker; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; excitatory amino acid antagonist; geroprotector; non-narcotic analgesic; xenobiotic |
lansoprazole | [no description available] | medium | 3 | 0 | benzimidazoles; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
beta-lapachone | [no description available] | medium | 1 | 0 | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
leflunomide | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; isoxazoles; monocarboxylic acid amide | antineoplastic agent; antiparasitic agent; EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; hepatotoxic agent; immunosuppressive agent; non-steroidal anti-inflammatory drug; prodrug; pyrimidine synthesis inhibitor; tyrosine kinase inhibitor |
linopirdine | [no description available] | medium | 1 | 0 | indoles | |
loratadine | [no description available] | medium | 1 | 0 | benzocycloheptapyridine; ethyl ester; N-acylpiperidine; organochlorine compound; tertiary carboxamide | anti-allergic agent; cholinergic antagonist; geroprotector; H1-receptor antagonist |
loxoprofen | [no description available] | medium | 1 | 0 | cyclopentanones; monocarboxylic acid | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug |
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | [no description available] | medium | 1 | 0 | chromones; morpholines; organochlorine compound | autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector |
meclofenamate sodium anhydrous | [no description available] | medium | 1 | 0 | organic sodium salt | |
methiothepin | [no description available] | medium | 1 | 0 | aryl sulfide; dibenzothiepine; N-alkylpiperazine; tertiary amino compound | antipsychotic agent; dopaminergic antagonist; geroprotector; serotonergic antagonist |
methoctramine | [no description available] | medium | 1 | 0 | aromatic ether; tetramine | muscarinic antagonist |
nocodazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester; thiophenes | antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator |
3-Hydroxy-alpha-methyl-DL-tyrosine | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | |
metolazone | [no description available] | medium | 3 | 0 | organochlorine compound; quinazolines; sulfonamide | antihypertensive agent; diuretic; ion transport inhibitor |
milrinone | [no description available] | medium | 3 | 0 | bipyridines; nitrile; pyridone | cardiotonic drug; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
minoxidil | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
mitotane | [no description available] | medium | 1 | 0 | diarylmethane | |
mitoxantrone | [no description available] | medium | 2 | 0 | dihydroxyanthraquinone | analgesic; antineoplastic agent |
ml 7 | [no description available] | medium | 1 | 0 | N-sulfonyldiazepane; organoiodine compound | EC 2.7.11.18 (myosin-light-chain kinase) inhibitor |
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | [no description available] | medium | 1 | 0 | naphthalenes; organochlorine compound; primary amino compound; sulfonamide | |
n-bromoacetamide | [no description available] | medium | 1 | 0 | | |
ethylmaleimide | [no description available] | medium | 1 | 0 | maleimides | anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor |
fg 7142 | [no description available] | medium | 1 | 0 | beta-carbolines | |
fenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; secondary amino compound | membrane transport modulator |
n 0840 | [no description available] | medium | 1 | 0 | | |
nialamide | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
niclosamide | [no description available] | medium | 1 | 0 | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor |
nifedipine | [no description available] | medium | 4 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
niflumic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
nilutamide | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; C-nitro compound; imidazolidinone | androgen antagonist; antineoplastic agent |
nimesulide | [no description available] | medium | 1 | 0 | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
nimodipine | [no description available] | medium | 3 | 0 | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent |
nipecotic acid | [no description available] | medium | 1 | 0 | beta-amino acid; piperidinemonocarboxylic acid | |
nitrendipine | [no description available] | medium | 2 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent |
masoprocol | [no description available] | medium | 1 | 0 | catechols; lignan; tetrol | antioxidant; ferroptosis inhibitor; geroprotector; plant metabolite |
5-nitro-2-(3-phenylpropylamino)benzoic acid | [no description available] | medium | 1 | 0 | nitrobenzoic acid | |
ns 2028 | [no description available] | medium | 1 | 0 | | |
ns 1619 | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; benzimidazoles; phenols | potassium channel opener |
o(6)-benzylguanine | [no description available] | medium | 1 | 0 | | |
ofloxacin | [no description available] | medium | 3 | 0 | 3-oxo monocarboxylic acid; N-arylpiperazine; N-methylpiperazine; organofluorine compound; oxazinoquinoline | |
olomoucine | [no description available] | medium | 1 | 0 | 2,6-diaminopurines; ethanolamines | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
oxaprozin | [no description available] | medium | 1 | 0 | 1,3-oxazoles; monocarboxylic acid | analgesic; non-steroidal anti-inflammatory drug |
oxatomide | [no description available] | medium | 1 | 0 | benzimidazoles; diarylmethane; N-alkylpiperazine | anti-allergic agent; anti-inflammatory agent; geroprotector; H1-receptor antagonist; serotonergic antagonist |
oxolinic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; organic heterotricyclic compound; oxacycle; quinolinemonocarboxylic acid; quinolone antibiotic | antibacterial drug; antifungal agent; antiinfective agent; antimicrobial agent; enzyme inhibitor |
quinone | [no description available] | medium | 1 | 0 | 1,4-benzoquinones | cofactor; human xenobiotic metabolite; mouse metabolite |
fenclonine | [no description available] | medium | 1 | 0 | phenylalanine derivative | |
palmidrol | [no description available] | medium | 1 | 0 | endocannabinoid; N-(long-chain-acyl)ethanolamine; N-(saturated fatty acyl)ethanolamine | anti-inflammatory drug; anticonvulsant; antihypertensive agent; neuroprotective agent |
1,7-dimethylxanthine | [no description available] | medium | 1 | 0 | dimethylxanthine | central nervous system stimulant; human blood serum metabolite; human xenobiotic metabolite; mouse metabolite |
pd 98059 | [no description available] | medium | 1 | 0 | aromatic amine; monomethoxyflavone | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector |
pentamidine | [no description available] | medium | 4 | 0 | aromatic ether; carboxamidine; diether | anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic |
pentoxifylline | [no description available] | medium | 2 | 0 | oxopurine | |
perphenazine | [no description available] | medium | 2 | 0 | N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines | antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug |
phenyl biguanide | [no description available] | medium | 1 | 0 | guanidines | central nervous system drug |
phenylbutazone | [no description available] | medium | 1 | 0 | pyrazolidines | antirheumatic drug; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug |
phloretin | [no description available] | medium | 1 | 0 | dihydrochalcones | antineoplastic agent; plant metabolite |
picotamide | [no description available] | medium | 1 | 0 | benzamides | |
pinacidil | [no description available] | medium | 1 | 0 | pyridines | |
pindolol | [no description available] | medium | 3 | 0 | indoles; secondary amine | antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent |
piperidine-4-sulfonic acid | [no description available] | medium | 1 | 0 | | |
pirenperone | [no description available] | medium | 1 | 0 | aromatic ketone | |
praziquantel | [no description available] | medium | 1 | 0 | isoquinolines | |
primidone | [no description available] | medium | 1 | 0 | pyrimidone | anticonvulsant; environmental contaminant; xenobiotic |
proglumide | [no description available] | medium | 1 | 0 | benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate | anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite |
propentofylline | [no description available] | medium | 1 | 0 | oxopurine | |
propofol | [no description available] | medium | 2 | 0 | phenols | anticonvulsant; antiemetic; intravenous anaesthetic; radical scavenger; sedative |
pf 5901 | [no description available] | medium | 1 | 0 | quinolines | |
riluzole | [no description available] | medium | 1 | 0 | benzothiazoles | |
risperidone | [no description available] | medium | 3 | 0 | 1,2-benzoxazoles; heteroarylpiperidine; organofluorine compound; pyridopyrimidine | alpha-adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; psychotropic drug; second generation antipsychotic; serotonergic antagonist |
ritanserin | [no description available] | medium | 1 | 0 | organofluorine compound; piperidines; thiazolopyrimidine | antidepressant; antipsychotic agent; anxiolytic drug; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist |
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone | [no description available] | medium | 1 | 0 | methoxybenzenes | |
rolipram | [no description available] | medium | 1 | 0 | pyrrolidin-2-ones | antidepressant; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
salmeterol xinafoate | [no description available] | medium | 1 | 0 | ether; phenols; primary alcohol; secondary alcohol; secondary amino compound | |
sb 202190 | [no description available] | medium | 1 | 0 | imidazoles; organofluorine compound; phenols; pyridines | apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
sobuzoxane | [no description available] | medium | 1 | 0 | organic molecular entity | |
spiroxatrine | [no description available] | medium | 1 | 0 | imidazolidines | |
sq 22536 | [no description available] | medium | 1 | 0 | nucleoside analogue; oxolanes | EC 4.6.1.1 (adenylate cyclase) inhibitor |
sulfaphenazole | [no description available] | medium | 1 | 0 | primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor |
sulpiride | [no description available] | medium | 2 | 0 | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
t0156 | [no description available] | medium | 1 | 0 | naphthyridine derivative | |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene | [no description available] | medium | 1 | 0 | | |
terfenadine | [no description available] | medium | 1 | 0 | diarylmethane | |
tetraisopropylpyrophosphamide | [no description available] | medium | 1 | 0 | phosphoramide | |
thalidomide | [no description available] | medium | 2 | 0 | phthalimides; piperidones | |
theobromine | [no description available] | medium | 1 | 0 | dimethylxanthine | adenosine receptor antagonist; bronchodilator agent; food component; human blood serum metabolite; mouse metabolite; plant metabolite; vasodilator agent |
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
tolazamide | [no description available] | medium | 1 | 0 | N-sulfonylurea | hypoglycemic agent; potassium channel blocker |
tolbutamide | [no description available] | medium | 3 | 0 | N-sulfonylurea | human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker |
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid | [no description available] | medium | 1 | 0 | | |
ici 136,753 | [no description available] | medium | 1 | 0 | pyrazolopyridine | |
triamterene | [no description available] | medium | 2 | 0 | pteridines | diuretic; sodium channel blocker |
trimethoprim | [no description available] | medium | 3 | 0 | aminopyrimidine; methoxybenzenes | antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic |
tropicamide | [no description available] | medium | 1 | 0 | acetamides | |
tyrphostin a9 | [no description available] | medium | 1 | 0 | alkylbenzene | geroprotector |
vigabatrin | [no description available] | medium | 1 | 0 | gamma-amino acid | anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor |
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine | [no description available] | medium | 1 | 0 | | |
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | [no description available] | medium | 1 | 0 | aromatic primary alcohol; furans; indazoles | antineoplastic agent; apoptosis inducer; platelet aggregation inhibitor; soluble guanylate cyclase activator; vasodilator agent |
zardaverine | [no description available] | medium | 1 | 0 | organofluorine compound; pyridazinone | anti-asthmatic drug; bronchodilator agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; peripheral nervous system drug |
cortisone acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
corticosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
reserpine | [no description available] | medium | 1 | 0 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
procaine hydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
isoproterenol hydrochloride | [no description available] | medium | 1 | 0 | catechols | |
histamine dihydrochloride | [no description available] | medium | 1 | 0 | | |
carbachol | [no description available] | medium | 2 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
spironolactone | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester | aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
estrone | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols | antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite |
androsterone | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3alpha-hydroxy steroid; androstanoid; C19-steroid | androgen; anticonvulsant; human blood serum metabolite; human metabolite; human urinary metabolite; mouse metabolite; pheromone |
promazine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
pilocarpine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
dimethylphenylpiperazinium iodide | [no description available] | medium | 1 | 0 | N-arylpiperazine; organic iodide salt; piperazinium salt; quaternary ammonium salt | nicotinic acetylcholine receptor agonist |
pentylenetetrazole | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
racepinephrine hydrochloride | [no description available] | medium | 1 | 0 | | |
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride | [no description available] | medium | 1 | 0 | | |
hexamethonium bromide | [no description available] | medium | 1 | 0 | | |
cystamine dihydrochloride | [no description available] | medium | 1 | 0 | | |
cantharidin | [no description available] | medium | 1 | 0 | cyclic dicarboxylic anhydride; monoterpenoid | EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; herbicide |
tetraethylammonium chloride | [no description available] | medium | 1 | 0 | organic chloride salt; quaternary ammonium salt | potassium channel blocker |
aspartic acid | [no description available] | medium | 3 | 0 | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
glutamine | [no description available] | medium | 2 | 0 | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
vincristine | [no description available] | medium | 2 | 0 | acetate ester; formamides; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; tertiary alcohol; tertiary amino compound; vinca alkaloid | antineoplastic agent; drug; microtubule-destabilising agent; plant metabolite; tubulin modulator |
physostigmine | [no description available] | medium | 5 | 0 | carbamate ester; indole alkaloid | antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic |
apomorphine | [no description available] | medium | 3 | 0 | aporphine alkaloid | alpha-adrenergic drug; antidyskinesia agent; antiparkinson drug; dopamine agonist; emetic; serotonergic drug |
promethazine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; geroprotector; H1-receptor antagonist; local anaesthetic; sedative |
bromodeoxyuridine | [no description available] | medium | 1 | 0 | pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent |
levodopa | [no description available] | medium | 2 | 0 | amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug |
methoxamine hydrochloride | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
papaverine hydrochloride | [no description available] | medium | 1 | 0 | | |
bretylium tosylate | [no description available] | medium | 1 | 0 | organosulfonate salt; quaternary ammonium salt | adrenergic antagonist; anti-arrhythmia drug; antihypertensive agent |
berlition | [no description available] | medium | 1 | 0 | dithiolanes; heterocyclic fatty acid; lipoic acid; thia fatty acid | cofactor; nutraceutical; prosthetic group |
methacholine chloride | [no description available] | medium | 1 | 0 | quaternary ammonium salt | |
androstenedione | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
colchicine | [no description available] | medium | 2 | 0 | alkaloid; colchicine | anti-inflammatory agent; gout suppressant; mutagen |
yohimbine hydrochloride | [no description available] | medium | 1 | 0 | | |
gallamine triethiodide | [no description available] | medium | 1 | 0 | | |
cycloheximide | [no description available] | medium | 3 | 0 | antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol | anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor |
egtazic acid | [no description available] | medium | 1 | 0 | diether; tertiary amino compound; tetracarboxylic acid | chelator |
cycloserine | [no description available] | medium | 2 | 0 | 4-amino-1,2-oxazolidin-3-one; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic; zwitterion | antiinfective agent; antimetabolite; antitubercular agent; metabolite; NMDA receptor agonist |
17-alpha-hydroxyprogesterone | [no description available] | medium | 1 | 0 | 17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone | human metabolite; metabolite; mouse metabolite; progestin |
quinacrine monohydrochloride | [no description available] | medium | 1 | 0 | | |
chlorpromazine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride; phenothiazines | anticoronaviral agent; phenothiazine antipsychotic drug |
cytarabine hydrochloride | [no description available] | medium | 1 | 0 | | |
tryptophan | [no description available] | medium | 2 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
lidocaine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug; local anaesthetic |
arginine | [no description available] | medium | 1 | 0 | arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical |
rotenone | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin |
synephrine | [no description available] | medium | 1 | 0 | ethanolamines; phenethylamine alkaloid; phenols | alpha-adrenergic agonist; plant metabolite |
pyridostigmine bromide | [no description available] | medium | 2 | 0 | pyridinium salt | |
imipramine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant |
neostigmine bromide | [no description available] | medium | 3 | 0 | bromide salt | |
edrophonium chloride | [no description available] | medium | 1 | 0 | chloride salt; quaternary ammonium salt | antidote; diagnostic agent; EC 3.1.1.8 (cholinesterase) inhibitor |
suramin sodium | [no description available] | medium | 1 | 0 | organic sodium salt | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
pyrazolanthrone | [no description available] | medium | 1 | 0 | anthrapyrazole; aromatic ketone; cyclic ketone | antineoplastic agent; c-Jun N-terminal kinase inhibitor; geroprotector |
methapyrilene hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-allergic agent; carcinogenic agent; H1-receptor antagonist; sedative |
tetrracaine hydrochloride | [no description available] | medium | 1 | 0 | benzoate ester | |
chelidamic acid | [no description available] | medium | 1 | 0 | | |
2-chloroadenosine | [no description available] | medium | 1 | 0 | purine nucleoside | |
diphenhydramine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride; organoammonium salt | anti-allergic agent; antiemetic; antiparkinson drug; antipruritic drug; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; sedative |
cysteamine hydrochloride | [no description available] | medium | 1 | 0 | | |
propantheline bromide | [no description available] | medium | 1 | 0 | xanthenes | |
hydralazine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antihypertensive agent; vasodilator agent |
ethamivan | [no description available] | medium | 1 | 0 | methoxybenzenes; phenols | |
pargyline hydrochloride | [no description available] | medium | 1 | 0 | | |
aminophylline | [no description available] | medium | 1 | 0 | mixture | bronchodilator agent; cardiotonic drug |
azacitidine | [no description available] | medium | 2 | 0 | N-glycosyl-1,3,5-triazine; nucleoside analogue | antineoplastic agent |
orphenadrine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antiparkinson drug; H1-receptor antagonist; muscarinic antagonist; muscle relaxant; NMDA receptor antagonist; parasympatholytic |
betamethasone | [no description available] | medium | 2 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | anti-asthmatic agent; anti-inflammatory drug; immunosuppressive agent |
benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide | [no description available] | medium | 1 | 0 | | |
cyproterone acetate | [no description available] | medium | 1 | 0 | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; chlorinated steroid; steroid ester | androgen antagonist; geroprotector; progestin |
bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
kainic acid | [no description available] | medium | 1 | 0 | dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid | antinematodal drug; excitatory amino acid agonist |
podophyllotoxin | [no description available] | medium | 1 | 0 | furonaphthodioxole; lignan; organic heterotetracyclic compound | antimitotic; antineoplastic agent; keratolytic drug; microtubule-destabilising agent; plant metabolite; tubulin modulator |
tetrahydrozoline hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | nasal decongestant; sympathomimetic agent; vasoconstrictor agent |
dequalinium chloride | [no description available] | medium | 3 | 0 | organic chloride salt | antifungal agent; antineoplastic agent; antiseptic drug; mitochondrial NADH:ubiquinone reductase inhibitor |
decamethonium dibromide | [no description available] | medium | 1 | 0 | | |
amitriptyline hydrochloride | [no description available] | medium | 1 | 0 | organic tricyclic compound | |
naphazoline hydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
doxylamine succinate | [no description available] | medium | 1 | 0 | organic molecular entity | |
carbamylhydrazine monohydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
formestane | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3-oxo-Delta(4) steroid; enol; hydroxy steroid | antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor |
debrisoquin sulfate | [no description available] | medium | 1 | 0 | organic sulfate salt | |
betaine hydrochloride | [no description available] | medium | 1 | 0 | | |
bethanechol chloride | [no description available] | medium | 1 | 0 | carbamate ester; chloride salt; quaternary ammonium salt | muscarinic agonist |
acetylcysteine | [no description available] | medium | 2 | 0 | acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid | antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary |
Mecamylamine hydrochloride | [no description available] | medium | 1 | 0 | monoterpenoid | |
vinblastine | [no description available] | medium | 3 | 0 | | |
cyproheptadine hydrochloride (anhydrous) | [no description available] | medium | 1 | 0 | hydrochloride | |
5 alpha-androstane-3 alpha,17 beta-diol | [no description available] | medium | 1 | 0 | androstane-3alpha,17beta-diol | Daphnia magna metabolite; human metabolite |
pimozide | [no description available] | medium | 1 | 0 | benzimidazoles; heteroarylpiperidine; organofluorine compound | antidyskinesia agent; dopaminergic antagonist; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
azetidyl-2-carboxylic acid | [no description available] | medium | 1 | 0 | azetidine-2-carboxylic acid | |
muscarine | [no description available] | medium | 1 | 0 | | |
antazoline hydrochloride | [no description available] | medium | 1 | 0 | | |
doxifluridine | [no description available] | medium | 3 | 0 | organofluorine compound; pyrimidine 5'-deoxyribonucleoside | antimetabolite; antineoplastic agent; prodrug |
meclofenoxate hydrochloride | [no description available] | medium | 1 | 0 | | |
clonidine hydrochloride | [no description available] | medium | 1 | 0 | dichlorobenzene | |
beclomethasone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; chlorinated steroid; corticosteroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | anti-asthmatic drug; anti-inflammatory drug |
buthionine sulfoximine | [no description available] | medium | 1 | 0 | diastereoisomeric mixture; homocysteines; non-proteinogenic alpha-amino acid; sulfoximide | EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor; ferroptosis inducer |
mexiletine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
cyclophosphamide | [no description available] | medium | 1 | 0 | hydrate | alkylating agent; antineoplastic agent; carcinogenic agent; immunosuppressive agent |
suxamethonium chloride | [no description available] | medium | 1 | 0 | chloride salt | muscle relaxant |
cyclobenzaprine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant; muscle relaxant |
n-methylaspartate | [no description available] | medium | 1 | 0 | amino dicarboxylic acid; D-alpha-amino acid; D-aspartic acid derivative; secondary amino compound | neurotransmitter agent |
3-deazaadenosine | [no description available] | medium | 1 | 0 | | |
metoclopramide hydrochloride | [no description available] | medium | 1 | 0 | | |
isoetharine mesylate | [no description available] | medium | 1 | 0 | | |
zalcitabine | [no description available] | medium | 3 | 0 | pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor |
propionylpromazine hydrochloride | [no description available] | medium | 1 | 0 | | |
camptothecin | [no description available] | medium | 1 | 0 | delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite |
nsc-145,668 | [no description available] | medium | 1 | 0 | hydrochloride | antimetabolite; antineoplastic agent |
clodronic acid | [no description available] | medium | 1 | 0 | 1,1-bis(phosphonic acid); one-carbon compound; organochlorine compound | antineoplastic agent; bone density conservation agent |
benserazide hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antiparkinson drug; dopaminergic agent; EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor |
pancuronium bromide | [no description available] | medium | 1 | 0 | bromide salt | cholinergic antagonist; muscle relaxant; nicotinic antagonist |
tetradecanoylphorbol acetate | [no description available] | medium | 1 | 0 | acetate ester; diester; phorbol ester; tertiary alpha-hydroxy ketone; tetradecanoate ester | antineoplastic agent; apoptosis inducer; carcinogenic agent; mitogen; plant metabolite; protein kinase C agonist; reactive oxygen species generator |
danazol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; terminal acetylenic compound | anti-estrogen; estrogen antagonist; geroprotector |
metergoline | [no description available] | medium | 1 | 0 | carbamate ester; ergoline alkaloid | dopamine agonist; geroprotector; serotonergic antagonist |
lisuride | [no description available] | medium | 1 | 0 | monocarboxylic acid amide | antidyskinesia agent; antiparkinson drug; dopamine agonist; serotonergic agonist |
disopyramide phosphate | [no description available] | medium | 1 | 0 | organoammonium phosphate | |
bromocriptine | [no description available] | medium | 1 | 0 | indole alkaloid | antidyskinesia agent; antiparkinson drug; dopamine agonist; hormone antagonist |
ergocristine | [no description available] | medium | 1 | 0 | ergot alkaloid | |
triamcinolone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 16alpha-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | anti-allergic agent; anti-inflammatory drug |
zidovudine | [no description available] | medium | 2 | 0 | azide; pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor |
paclitaxel | [no description available] | medium | 2 | 0 | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
buspirone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist |
etoposide | [no description available] | medium | 3 | 0 | beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound | antineoplastic agent; DNA synthesis inhibitor |
propafenone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
etazolate hydrochloride | [no description available] | medium | 1 | 0 | | |
butaclamol | [no description available] | medium | 1 | 0 | amino alcohol; organic heteropentacyclic compound; tertiary alcohol; tertiary amino compound | dopaminergic antagonist |
ribavirin | [no description available] | medium | 2 | 0 | 1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide | anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
carbidopa | [no description available] | medium | 1 | 0 | catechols; hydrate; hydrazines; monocarboxylic acid | antidyskinesia agent; antiparkinson drug; dopaminergic agent; EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor |
cephradine | [no description available] | medium | 3 | 0 | beta-lactam antibiotic allergen; cephalosporin | antibacterial drug |
methyldopa | [no description available] | medium | 3 | 0 | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
lonidamine | [no description available] | medium | 1 | 0 | dichlorobenzene; indazoles; monocarboxylic acid | antineoplastic agent; antispermatogenic agent; EC 2.7.1.1 (hexokinase) inhibitor; geroprotector |
dexibuprofen | [no description available] | medium | 1 | 0 | ibuprofen | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
quisqualic acid | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid | |
pirfenidone | [no description available] | medium | 1 | 0 | pyridone | antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
flecainide acetate | [no description available] | medium | 1 | 0 | acetate salt | anti-arrhythmia drug |
nicardipine hydrochloride | [no description available] | medium | 1 | 0 | dihydropyridine | geroprotector |
idarubicin | [no description available] | medium | 2 | 0 | anthracycline antibiotic; deoxy hexoside; monosaccharide derivative | |
captopril | [no description available] | medium | 5 | 0 | alkanethiol; L-proline derivative; N-acylpyrrolidine; pyrrolidinemonocarboxylic acid | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
terazosin hydrochloride anhydrous | [no description available] | medium | 1 | 0 | | |
pergolide mesylate | [no description available] | medium | 1 | 0 | methanesulfonate salt | antiparkinson drug; dopamine agonist; geroprotector |
ranitidine hydrochloride | [no description available] | medium | 1 | 0 | | |
colforsin | [no description available] | medium | 1 | 0 | acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol | adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist |
cefaclor anhydrous | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug; drug allergen |
alo 2145 | [no description available] | medium | 1 | 0 | hydrochloride | alpha-adrenergic agonist; antiglaucoma drug |
enoximone | [no description available] | medium | 2 | 0 | aromatic ketone | |
atomoxetine | [no description available] | medium | 3 | 0 | aromatic ether; secondary amino compound; toluenes | adrenergic uptake inhibitor; antidepressant; environmental contaminant; xenobiotic |
raloxifene hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | bone density conservation agent; estrogen antagonist; estrogen receptor modulator |
mifepristone | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; acetylenic compound; tertiary amino compound | abortifacient; contraceptive drug; hormone antagonist; synthetic oral contraceptive |
quinpirole hydrochloride | [no description available] | medium | 1 | 0 | | |
imazodan | [no description available] | medium | 1 | 0 | | |
mibefradil dihydrochloride | [no description available] | medium | 1 | 0 | | |
aptiganel hydrochloride | [no description available] | medium | 1 | 0 | | |
adenosine | [no description available] | medium | 1 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
phenelzine sulfate | [no description available] | medium | 1 | 0 | organic molecular entity | |
fluoxetine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | |
propranolol hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
bupropion hydrochloride | [no description available] | medium | 1 | 0 | aromatic ketone | |
diltiazem hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antihypertensive agent; calcium channel blocker; vasodilator agent |
trazodone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | adrenergic antagonist; antidepressant; H1-receptor antagonist; sedative; serotonin uptake inhibitor |
verapamil hydrochloride | [no description available] | medium | 1 | 0 | | |
doxazosin mesylate | [no description available] | medium | 1 | 0 | methanesulfonate salt | geroprotector |
amantadine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antiviral agent; dopamine agonist; NMDA receptor antagonist |
mevastatin | [no description available] | medium | 1 | 0 | 2-pyranones; carboxylic ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | antifungal agent; apoptosis inducer; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; fungal metabolite; Penicillium metabolite |
chloroquine diphosphate | [no description available] | medium | 1 | 0 | | |
dobutamine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | beta-adrenergic agonist; cardiotonic drug; sympathomimetic agent |
desipramine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | drug allergen |
dopamine hydrochloride | [no description available] | medium | 1 | 0 | catecholamine | |
proadifen hydrochloride | [no description available] | medium | 1 | 0 | | |
4-nitrobenzylthioinosine | [no description available] | medium | 1 | 0 | purine nucleoside | |
metrifudil | [no description available] | medium | 1 | 0 | | |
rutecarpine | [no description available] | medium | 1 | 0 | beta-carbolines | |
trihexyphenidyl hydrochloride | [no description available] | medium | 1 | 0 | aralkylamine | |
thioridazine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | first generation antipsychotic; geroprotector |
procainamide hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
siquil | [no description available] | medium | 1 | 0 | hydrochloride | anticoronaviral agent |
sotalol hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug; beta-adrenergic antagonist |
oxymetazoline hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | alpha-adrenergic agonist; nasal decongestant; sympathomimetic agent; vasoconstrictor agent |
alprenolol hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
2-methoxyestradiol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-hydroxy steroid | angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite |
fluphenazine hydrochloride | [no description available] | medium | 1 | 0 | phenothiazines | anticoronaviral agent |
tryptamine monohydrochloride | [no description available] | medium | 1 | 0 | | |
clomipramine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anticoronaviral agent; antidepressant; serotonergic antagonist; serotonergic drug |
amiloride hydrochloride | [no description available] | medium | 1 | 0 | hydrate | diuretic; sodium channel blocker |
prazosin hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
mianserin hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | geroprotector |
lomefloxacin hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antimicrobial agent; antitubercular agent; photosensitizing agent |
fenspiride hydrochloride | [no description available] | medium | 1 | 0 | | |
nilverm | [no description available] | medium | 1 | 0 | organic molecular entity | |
sanguinarine chloride | [no description available] | medium | 1 | 0 | | |
ropinirole hydrochloride | [no description available] | medium | 1 | 0 | indoles | |
plasmenylserine | [no description available] | medium | 3 | 0 | O-phosphoserine | EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor; EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
5-aminovaleric acid hydrochloride | [no description available] | medium | 1 | 0 | | |
n-acetyltryptamine | [no description available] | medium | 1 | 0 | acetamides; indoles | |
D-serine | [no description available] | medium | 1 | 0 | D-alpha-amino acid; serine zwitterion; serine | Escherichia coli metabolite; human metabolite; NMDA receptor agonist |
dihydroergotamine mesylate | [no description available] | medium | 1 | 0 | methanesulfonate salt | non-narcotic analgesic; serotonergic agonist; vasoconstrictor agent |
ranolazine hydrochloride | [no description available] | medium | 1 | 0 | | |
loxapine succinate | [no description available] | medium | 1 | 0 | succinate salt | geroprotector |
guanfacine hydrochloride | [no description available] | medium | 1 | 0 | acetamides | geroprotector |
pirenzepine dihydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
labetalol hydrochloride | [no description available] | medium | 1 | 0 | salicylamides | |
acecainide hydrochloride | [no description available] | medium | 1 | 0 | | |
loperamide hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist |
maprotiline hydrochloride | [no description available] | medium | 1 | 0 | anthracenes | |
protoporphyrin ix, disodium salt | [no description available] | medium | 1 | 0 | | |
siguazodan | [no description available] | medium | 1 | 0 | pyridazinone | |
3-octadecanamido-2-ethoxypropylphosphocholine | [no description available] | medium | 1 | 0 | | |
chelerythrine chloride | [no description available] | medium | 1 | 0 | | |
tosyllysine chloromethyl ketone | [no description available] | medium | 1 | 0 | | |
5-(n-methyl-n-isobutyl)amiloride | [no description available] | medium | 1 | 0 | | |
1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | EC 2.7.11.13 (protein kinase C) inhibitor |
amperozide hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anxiolytic drug; dopamine uptake inhibitor; geroprotector; second generation antipsychotic; serotonergic antagonist |
pyrrolidine dithiocarbamic acid | [no description available] | medium | 1 | 0 | | |
agroclavine | [no description available] | medium | 1 | 0 | ergot alkaloid | |
s-methylisothiourea sulfate | [no description available] | medium | 1 | 0 | | |
p-Aminobenzamidine dihydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
benzamidine hydrochloride | [no description available] | medium | 1 | 0 | | |
ketorolac tromethamine | [no description available] | medium | 1 | 0 | organoammonium salt | analgesic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor |
methionine sulfoximine | [no description available] | medium | 1 | 0 | L-alpha-amino acid zwitterion; L-methionine derivative; methionine sulfoximine; non-proteinogenic L-alpha-amino acid | EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor; geroprotector |
tretazicar | [no description available] | medium | 1 | 0 | | |
carbetapentane citrate | [no description available] | medium | 1 | 0 | carbonyl compound | |
phentolamine mesylate | [no description available] | medium | 1 | 0 | | |
mephentermine | [no description available] | medium | 1 | 0 | 2-aminooctadecane-1,3-diol | EC 2.7.11.13 (protein kinase C) inhibitor; human metabolite; mouse metabolite |
oxybutynin hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
nimustine | [no description available] | medium | 1 | 0 | hydrochloride | antineoplastic agent |
cordium | [no description available] | medium | 1 | 0 | hydrate; hydrochloride | |
L-2-aminoadipic acid | [no description available] | medium | 1 | 0 | 2-aminoadipic acid | Escherichia coli metabolite; human metabolite |
prilocaine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | local anaesthetic |
mor-14 | [no description available] | medium | 1 | 0 | hydroxypiperidine; piperidine alkaloid; tertiary amino compound | anti-HIV agent; cardioprotective agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; plant metabolite |
brexanolone | [no description available] | medium | 1 | 0 | 3-hydroxy-5alpha-pregnan-20-one | antidepressant; GABA modulator; human metabolite; intravenous anaesthetic; sedative |
phenylisopropyladenosine | [no description available] | medium | 1 | 0 | aromatic amine; benzenes; hydrocarbyladenosine; purine nucleoside; secondary amino compound | adenosine A1 receptor agonist; neuroprotective agent |
hexamethonium chloride | [no description available] | medium | 1 | 0 | | |
6-(4-nitrobenzylthio)guanosine | [no description available] | medium | 1 | 0 | | |
3-aminopropylphosphonic acid | [no description available] | medium | 1 | 0 | phosphonic acids; primary amino compound; zwitterion | GABAB receptor agonist |
5'-n-methylcarboxamideadenosine | [no description available] | medium | 1 | 0 | | |
3,7-dimethyl-1-propargylxanthine | [no description available] | medium | 1 | 0 | | |
zpck | [no description available] | medium | 1 | 0 | | |
n(6)-phenyladenosine | [no description available] | medium | 1 | 0 | purine nucleoside | |
tetrahydrodeoxycorticosterone | [no description available] | medium | 1 | 0 | 21-hydroxy steroid | |
n-methyladenosine | [no description available] | medium | 1 | 0 | methyladenosine | |
mizoribine | [no description available] | medium | 1 | 0 | imidazoles | anticoronaviral agent |
1-amino-1,3-dicarboxycyclopentane | [no description available] | medium | 1 | 0 | | |
u 73122 | [no description available] | medium | 1 | 0 | aromatic ether; aza-steroid; maleimides | EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor |
alphaxalone | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
s-nitrosoglutathione | [no description available] | medium | 1 | 0 | glutathione derivative; nitrosothio compound | bronchodilator agent; nitric oxide donor; platelet aggregation inhibitor; signalling molecule |
cp-55,940 | [no description available] | medium | 1 | 0 | | |
vanoxerine | [no description available] | medium | 1 | 0 | hydrochloride | dopamine uptake inhibitor |
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate | [no description available] | medium | 1 | 0 | beta-carbolines | |
u 69593 | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; N-alkylpyrrolidine; organic heterobicyclic compound; oxaspiro compound | anti-inflammatory agent; diuretic; kappa-opioid receptor agonist |
cv 3988 | [no description available] | medium | 1 | 0 | | |
beta-carboline-3-carboxylic acid methyl ester | [no description available] | medium | 1 | 0 | beta-carbolines | |
methoctramine | [no description available] | medium | 1 | 0 | hydrochloride | muscarinic antagonist |
hypotaurine | [no description available] | medium | 1 | 0 | aminosulfinic acid; zwitterion | human metabolite; metabolite; mouse metabolite |
dihydrokainate | [no description available] | medium | 1 | 0 | dicarboxylic acid | |
gabazine | [no description available] | medium | 1 | 0 | | |
cl 218872 | [no description available] | medium | 1 | 0 | pyridazines; ring assembly | |
betaxolol hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antihypertensive agent; beta-adrenergic antagonist |
catechin | [no description available] | medium | 1 | 0 | hydrate | geroprotector |
1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine | [no description available] | medium | 1 | 0 | hydrobromide | serotonergic antagonist |
s-methylthiocitrulline | [no description available] | medium | 1 | 0 | imidothiocarbamic ester; L-arginine derivative; L-ornithine derivative; non-proteinogenic L-alpha-amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; neuroprotective agent |
dihydrocapsaicin | [no description available] | medium | 1 | 0 | capsaicinoid | |
ml 9 | [no description available] | medium | 1 | 0 | | |
parthenolide | [no description available] | medium | 1 | 0 | germacranolide | |
3',4'-dichlorobenzamil | [no description available] | medium | 3 | 0 | guanidines; pyrazines | |
1-(carboxymethylthio)tetradecane | [no description available] | medium | 1 | 0 | straight-chain fatty acid | |
2-iodomelatonin | [no description available] | medium | 1 | 0 | acetamides | |
arcaine, sulfate | [no description available] | medium | 1 | 0 | | |
gr 113808 | [no description available] | medium | 1 | 0 | indolyl carboxylate ester; piperidines; sulfonamide | serotonergic antagonist |
gallopamil hydrochloride | [no description available] | medium | 1 | 0 | | |
gamma-glutamylaminomethylsulfonic acid | [no description available] | medium | 1 | 0 | | |
buthionine sulfoximine | [no description available] | medium | 1 | 0 | 2-amino-4-(S-butylsulfonimidoyl)butanoic acid | EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor; ferroptosis inducer |
sb 204070a | [no description available] | medium | 1 | 0 | | |
1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; N-alkylpiperazine; N-arylpiperazine; primary arylamine; substituted aniline | geroprotector; serotonergic agonist |
l 655240 | [no description available] | medium | 1 | 0 | methylindole | |
san 58035 | [no description available] | medium | 1 | 0 | | |
nnc 711 | [no description available] | medium | 1 | 0 | | |
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide | [no description available] | medium | 1 | 0 | diarylmethane | |
e 64 | [no description available] | medium | 1 | 0 | dicarboxylic acid monoamide; epoxy monocarboxylic acid; guanidines; L-leucine derivative; zwitterion | antimalarial; antiparasitic agent; protease inhibitor |
azetidine-2,4-dicarboxylic acid | [no description available] | medium | 1 | 0 | | |
pre 084 | [no description available] | medium | 1 | 0 | morpholines | |
methotrexate | [no description available] | medium | 3 | 0 | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent |
1-(2-allylphenoxy)-3-((8-bromoacetylamino-4-menthane-1-yl)amino)-1-propanol | [no description available] | medium | 1 | 0 | | |
sr 2640 | [no description available] | medium | 1 | 0 | quinolines | |
ici 204448 | [no description available] | medium | 1 | 0 | | |
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride | [no description available] | medium | 1 | 0 | | |
n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide | [no description available] | medium | 1 | 0 | phenylindole | |
3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan | [no description available] | medium | 1 | 0 | | |
8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine | [no description available] | medium | 1 | 0 | | |
l 741626 | [no description available] | medium | 1 | 0 | piperidines | |
nisoxetine hydrochloride | [no description available] | medium | 1 | 0 | | |
ng-nitroarginine methyl ester | [no description available] | medium | 1 | 0 | hydrochloride | EC 1.14.13.39 (nitric oxide synthase) inhibitor |
tilarginine acetate | [no description available] | medium | 1 | 0 | | |
alpha-guanidinoglutaric acid | [no description available] | medium | 1 | 0 | L-glutamic acid derivative | |
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-isomer | [no description available] | medium | 1 | 0 | | |
imidazole-4-acetic acid hydrochloride | [no description available] | medium | 1 | 0 | | |
nsc-141549 | [no description available] | medium | 1 | 0 | | |
2-chloro-2-deoxyglucose | [no description available] | medium | 1 | 0 | | |
idazoxan hydrochloride | [no description available] | medium | 1 | 0 | | |
isoguvacine hydrochloride | [no description available] | medium | 1 | 0 | | |
8-methoxymethyl-3-isobutyl-1-methylxanthine | [no description available] | medium | 1 | 0 | oxopurine | |
cyc 202 | [no description available] | medium | 1 | 0 | 2,6-diaminopurines | antiviral drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
Serotonin hydrochloride | [no description available] | medium | 1 | 0 | tryptamines | |
n-phthaloylglutamic acid | [no description available] | medium | 1 | 0 | L-glutamic acid derivative; phthalimides | |
1,3-dipropyl-7-methylxanthine | [no description available] | medium | 1 | 0 | | |
ag 3-5 | [no description available] | medium | 1 | 0 | C-nitro compound | |
n-n-propylnorapomorphine | [no description available] | medium | 1 | 0 | aporphine alkaloid | |
urapidil monohydrochloride | [no description available] | medium | 1 | 0 | | |
aminopterin | [no description available] | medium | 1 | 0 | dicarboxylic acid | EC 1.5.1.3 (dihydrofolate reductase) inhibitor; mutagen |
azepexole, dihydrochloride | [no description available] | medium | 1 | 0 | | |
2,5-dimethoxy-4-iodoamphetamine hydrochloride | [no description available] | medium | 1 | 0 | | |
abt 980 | [no description available] | medium | 1 | 0 | | |
sk&f 75670 | [no description available] | medium | 1 | 0 | | |
esatenolol | [no description available] | medium | 1 | 0 | atenolol | beta-adrenergic antagonist |
nbi 27914 | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
sb 216763 | [no description available] | medium | 1 | 0 | indoles; maleimides | |
(R)-atenolol | [no description available] | medium | 1 | 0 | atenolol | |
memantine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist |
pefabloc | [no description available] | medium | 1 | 0 | | |
pongidae | [no description available] | medium | 1 | 0 | | |
succinylproline | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
sb 205384 | [no description available] | medium | 1 | 0 | thienopyridine | |
hydrastine | [no description available] | medium | 1 | 0 | isoquinolines | metabolite |
gabaculine hydrochloride | [no description available] | medium | 1 | 0 | | |
etiron monohydrobromide | [no description available] | medium | 1 | 0 | | |
bmy 7378 | [no description available] | medium | 1 | 0 | | |
vesamicol | [no description available] | medium | 1 | 0 | | |
cortisone | [no description available] | medium | 1 | 0 | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite |
vincristine sulfate | [no description available] | medium | 1 | 0 | organic sulfate salt | antineoplastic agent; geroprotector |
n-methylserotonin oxalate salt | [no description available] | medium | 1 | 0 | | |
nsc 95397 | [no description available] | medium | 1 | 0 | 1,4-naphthoquinones | |
wortmannin | [no description available] | medium | 1 | 0 | acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound | anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent |
lithium chloride | [no description available] | medium | 1 | 0 | inorganic chloride; lithium salt | antimanic drug; geroprotector |
canavanine | [no description available] | medium | 1 | 0 | amino acid zwitterion; non-proteinogenic L-alpha-amino acid | phytogenic insecticide; plant metabolite |
5-hydroxytryptophan | [no description available] | medium | 1 | 0 | 5-hydroxytryptophan; amino acid zwitterion; hydroxy-L-tryptophan; non-proteinogenic L-alpha-amino acid | human metabolite; mouse metabolite; plant metabolite |
ouabain | [no description available] | medium | 1 | 0 | 11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone | anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite |
tosylphenylalanyl chloromethyl ketone | [no description available] | medium | 1 | 0 | alpha-chloroketone; sulfonamide | alkylating agent; serine proteinase inhibitor |
monoiodotyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion; L-tyrosine derivative; monoiodotyrosine; non-proteinogenic L-alpha-amino acid | EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor; human metabolite; mouse metabolite |
nitroarginine | [no description available] | medium | 1 | 0 | guanidines; L-arginine derivative; N-nitro compound; non-proteinogenic L-alpha-amino acid | |
willardiine | [no description available] | medium | 1 | 0 | amino acid zwitterion; L-alanine derivative; non-proteinogenic L-alpha-amino acid | |
cortodoxone | [no description available] | medium | 1 | 0 | deoxycortisol; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite |
amiodarone hydrochloride | [no description available] | medium | 1 | 0 | aromatic ketone | |
dicyclomine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antispasmodic drug; muscarinic antagonist |
metyrosine | [no description available] | medium | 1 | 0 | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | antihypertensive agent; EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor |
nortriptyline hydrochloride | [no description available] | medium | 1 | 0 | organic tricyclic compound | geroprotector |
paromomycin sulfate | [no description available] | medium | 1 | 0 | | |
Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
cyclopamine | [no description available] | medium | 1 | 0 | piperidines | glioma-associated oncogene inhibitor |
s-(4-azidophenacyl)glutathione | [no description available] | medium | 1 | 0 | peptide | |
hydroxylamine hydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
sb 228357 | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
3,5-dihydroxyphenylglycine | [no description available] | medium | 1 | 0 | amino acid zwitterion; non-proteinogenic L-alpha-amino acid; resorcinols | |
actinonin | [no description available] | medium | 1 | 0 | | |
vinpocetine | [no description available] | medium | 1 | 0 | alkaloid | geroprotector |
dihydroergocristine monomesylate | [no description available] | medium | 1 | 0 | methanesulfonate salt | alpha-adrenergic antagonist; geroprotector; vasodilator agent |
tretinoin | [no description available] | medium | 1 | 0 | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule |
resveratrol | [no description available] | medium | 1 | 0 | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
oleic acid | [no description available] | medium | 1 | 0 | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent |
thapsigargin | [no description available] | medium | 1 | 0 | butyrate ester; organic heterotricyclic compound; sesquiterpene lactone | calcium channel blocker; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor |
brivudine | [no description available] | medium | 1 | 0 | | |
5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol | [no description available] | medium | 1 | 0 | carbotetracyclic compound; polyphenol | estrogen receptor agonist; estrogen receptor antagonist; geroprotector; neuroprotective agent |
2-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid | [no description available] | medium | 1 | 0 | | |
adenosine-5'-(n-ethylcarboxamide) | [no description available] | medium | 1 | 0 | adenosines; monocarboxylic acid amide | adenosine A1 receptor agonist; adenosine A2A receptor agonist; antineoplastic agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |
L-cycloserine | [no description available] | medium | 1 | 0 | 4-amino-1,2-oxazolidin-3-one | anti-HIV agent; anticonvulsant; EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor |
1,4-dideoxy-1,4-imino-d-arabinitol | [no description available] | medium | 1 | 0 | | |
purvalanol a | [no description available] | medium | 1 | 0 | purvalanol | |
melphalan | [no description available] | medium | 2 | 0 | L-phenylalanine derivative; nitrogen mustard; non-proteinogenic L-alpha-amino acid; organochlorine compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent |
isoliquiritigenin | [no description available] | medium | 1 | 0 | chalcones | antineoplastic agent; biological pigment; EC 1.14.18.1 (tyrosinase) inhibitor; GABA modulator; geroprotector; metabolite; NMDA receptor antagonist |
rauwolscine | [no description available] | medium | 1 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | |
gw9662 | [no description available] | medium | 1 | 0 | benzamides | |
calmidazolium | [no description available] | medium | 1 | 0 | organic chloride salt | apoptosis inducer; calmodulin antagonist |
tropisetron hydrochloride | [no description available] | medium | 1 | 0 | | |
Reactive blue 2 | [no description available] | medium | 1 | 0 | anthraquinone | |
5,6-dichloro-1-ethyl-1,3-dihydro-2h-benzimidazol-2-one | [no description available] | medium | 1 | 0 | dichlorobenzene | |
quinidine sulfate | [no description available] | medium | 1 | 0 | | |
ipratropium bromide anhydrous | [no description available] | medium | 1 | 0 | | |
methamilane methiodide | [no description available] | medium | 1 | 0 | | |
pilocarpine nitrate | [no description available] | medium | 1 | 0 | | |
r 59949 | [no description available] | medium | 1 | 0 | diarylmethane | |
n(6)-cyclopentyladenosine | [no description available] | medium | 1 | 0 | | |
methylatropine nitrate | [no description available] | medium | 1 | 0 | | |
sb 366791 | [no description available] | medium | 1 | 0 | | |
ag-213 | [no description available] | medium | 1 | 0 | | |
3,3',4,5'-tetrahydroxystilbene | [no description available] | medium | 1 | 0 | catechols; polyphenol; resorcinols; stilbenol | antineoplastic agent; apoptosis inducer; geroprotector; hypoglycemic agent; plant metabolite; protein kinase inhibitor; tyrosine kinase inhibitor |
bemesetron | [no description available] | medium | 1 | 0 | | |
(S)-(-)-pindolol | [no description available] | medium | 1 | 0 | pindolol | |
levosulpiride | [no description available] | medium | 1 | 0 | sulpiride | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
caffeic acid | [no description available] | medium | 1 | 0 | caffeic acid | geroprotector; mouse metabolite |
4-fluorophenyl-L-alanine | [no description available] | medium | 1 | 0 | 4-fluorophenylalanine; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid | |
urocanic acid | [no description available] | medium | 1 | 0 | urocanic acid | human metabolite |
cotinine | [no description available] | medium | 3 | 0 | N-alkylpyrrolidine; pyridines; pyrrolidin-2-ones; pyrrolidine alkaloid | antidepressant; biomarker; human xenobiotic metabolite; plant metabolite |
cinnarizine | [no description available] | medium | 1 | 0 | diarylmethane; N-alkylpiperazine; olefinic compound | anti-allergic agent; antiemetic; calcium channel blocker; geroprotector; H1-receptor antagonist; histamine antagonist; muscarinic antagonist |
sulindac | [no description available] | medium | 1 | 0 | monocarboxylic acid; organofluorine compound; sulfoxide | analgesic; antineoplastic agent; antipyretic; apoptosis inducer; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug; tocolytic agent |
cysteine sulfinic acid | [no description available] | medium | 1 | 0 | organosulfinic acid; S-substituted L-cysteine | Escherichia coli metabolite; human metabolite; metabotropic glutamate receptor agonist; mouse metabolite |
d-ap7 | [no description available] | medium | 1 | 0 | | |
(1R,2S)-tranylcypromine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
tacrine hydrochloride | [no description available] | medium | 1 | 0 | | |
4-bromotetramisole, oxalate (1:1), salt(s)-isomer | [no description available] | medium | 1 | 0 | | |
3-hydroxybenzylhydrazine hydrochloride | [no description available] | medium | 1 | 0 | | |
1-(3-chlorophenyl)biguanide hydrochloride | [no description available] | medium | 1 | 0 | | |
4-chlorophenylalanine methyl ester, hydrochloride, (dl)-isomer | [no description available] | medium | 1 | 0 | | |
capsazepine | [no description available] | medium | 1 | 0 | benzazepine; catechols; monochlorobenzenes; thioureas | capsaicin receptor antagonist |
diphenyleneiodium chloride | [no description available] | medium | 1 | 0 | organic chloride salt | EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor; G-protein-coupled receptor agonist |
azetidine-2,4-dicarboxylic acid, (cis)-isomer | [no description available] | medium | 1 | 0 | | |
tamoxifen citrate | [no description available] | medium | 1 | 0 | citrate salt | angiogenesis inhibitor; anticoronaviral agent |
pimagedine hydrochloride | [no description available] | medium | 1 | 0 | | |
Betaine Aldehyde Chloride | [no description available] | medium | 1 | 0 | quaternary ammonium salt | |
eskazine | [no description available] | medium | 1 | 0 | | |
monastrol | [no description available] | medium | 1 | 0 | enoate ester; ethyl ester; phenols; racemate; thioureas | antileishmanial agent; antimitotic; antineoplastic agent; EC 3.5.1.5 (urease) inhibitor |
u 0126 | [no description available] | medium | 1 | 0 | aryl sulfide; dinitrile; enamine; substituted aniline | antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent |
4-diphenylacetoxy-n-methylpiperidine methiodide | [no description available] | medium | 1 | 0 | iodide salt; quaternary ammonium salt | cholinergic antagonist; muscarinic antagonist |
1-(4-hydroxybenzyl)imidazole-2-thiol | [no description available] | medium | 1 | 0 | | |
2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide | [no description available] | medium | 1 | 0 | | |
bp 897 | [no description available] | medium | 1 | 0 | naphthalenecarboxamide | |
trequinsin hydrochloride | [no description available] | medium | 1 | 0 | | |
neboglamine | [no description available] | medium | 1 | 0 | | |
benzatropine methanesulfonate | [no description available] | medium | 1 | 0 | | |
sb 203186 | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
n-(1-methyl-5-indolyl)-n'-(3-methyl-5-isothiazolyl)urea | [no description available] | medium | 1 | 0 | 1,2-thiazoles; indoles; ureas | receptor modulator; serotonergic antagonist |
gw 7647 | [no description available] | medium | 1 | 0 | aryl sulfide; monocarboxylic acid; ureas | PPARalpha agonist |
ro 41-0960 | [no description available] | medium | 1 | 0 | | |
cgp 13501 | [no description available] | medium | 1 | 0 | alkylbenzene | |
n-(2-(4-(4-chlorophenyl)piperazin-1-yl)ethyl)-3-methoxybenzamide | [no description available] | medium | 1 | 0 | | |
brl 15572 | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; secondary alcohol | geroprotector; serotonergic antagonist |
mrs 1523 | [no description available] | medium | 1 | 0 | | |
or486 | [no description available] | medium | 1 | 0 | | |
fg 9041 | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
iik7 | [no description available] | medium | 1 | 0 | | |
sb 415286 | [no description available] | medium | 1 | 0 | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent |
dm 235 | [no description available] | medium | 1 | 0 | | |
jhw 015 | [no description available] | medium | 1 | 0 | indolecarboxamide | |
bw 723c86 | [no description available] | medium | 1 | 0 | tryptamines | |
sc 560 | [no description available] | medium | 1 | 0 | aromatic ether; monochlorobenzenes; organofluorine compound; pyrazoles | angiogenesis modulating agent; antineoplastic agent; apoptosis inducer; cyclooxygenase 1 inhibitor; non-steroidal anti-inflammatory drug |
sc-19220 | [no description available] | medium | 1 | 0 | aromatic ether | |
le 300 | [no description available] | medium | 1 | 0 | indoles | |
ly 367265 | [no description available] | medium | 1 | 0 | dihydropyridine; fluoroindole; tertiary amino compound; thiadiazoloquinoline | antidepressant; geroprotector; serotonergic antagonist; serotonin uptake inhibitor |
diclofenac sodium | [no description available] | medium | 1 | 0 | organic sodium salt | |
cgp 7930 | [no description available] | medium | 1 | 0 | alkylbenzene | |
1,3,5-tris(4-hydroxyphenyl)-4-propyl-1h-pyrazole | [no description available] | medium | 1 | 0 | phenols; pyrazoles | estrogen receptor agonist |
sib 1757 | [no description available] | medium | 1 | 0 | | |
sphingosine | [no description available] | medium | 1 | 0 | sphing-4-enine | human metabolite; mouse metabolite |
apigenin | [no description available] | medium | 1 | 0 | trihydroxyflavone | antineoplastic agent; metabolite |
luteolin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavonoid; tetrahydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist |
daphnetin | [no description available] | medium | 1 | 0 | hydroxycoumarin | |
genistein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
pulmicort | [no description available] | medium | 3 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone | anti-inflammatory drug; bronchodilator agent; drug allergen |
timolol maleate | [no description available] | medium | 1 | 0 | maleate salt | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
brompheniramine maleate | [no description available] | medium | 1 | 0 | maleate salt | anti-allergic agent |
chlorpheniramine maleate | [no description available] | medium | 1 | 0 | organic molecular entity | |
clemastine fumarate | [no description available] | medium | 1 | 0 | fumarate salt | anti-allergic agent; antipruritic drug; H1-receptor antagonist; muscarinic antagonist |
methylergonovine maleate | [no description available] | medium | 1 | 0 | ergoline alkaloid | geroprotector |
astaxanthine | [no description available] | medium | 1 | 0 | carotenol; carotenone | animal metabolite; anticoagulant; antioxidant; food colouring; plant metabolite |
harman | [no description available] | medium | 1 | 0 | harmala alkaloid; indole alkaloid fundamental parent; indole alkaloid | anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite |
morin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent |
myricetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; hexahydroxyflavone | antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite |
daidzein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; phytoestrogen; plant metabolite |
caffeic acid phenethyl ester | [no description available] | medium | 1 | 0 | alkyl caffeate ester | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent |
rottlerin | [no description available] | medium | 1 | 0 | aromatic ketone; benzenetriol; chromenol; enone; methyl ketone | anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite |
flupenthixol | [no description available] | medium | 1 | 0 | flupenthixol | dopaminergic antagonist |
n-oleoyldopamine | [no description available] | medium | 1 | 0 | catechols; fatty amide; N-(fatty acyl)-dopamine; secondary carboxamide | TRPV1 agonist |
pheniramine maleate | [no description available] | medium | 1 | 0 | organic molecular entity | |
tranilast | [no description available] | medium | 1 | 0 | amidobenzoic acid; cinnamamides; dimethoxybenzene; secondary carboxamide | anti-allergic agent; anti-asthmatic drug; antineoplastic agent; aryl hydrocarbon receptor agonist; calcium channel blocker; hepatoprotective agent; nephroprotective agent |
trimipramine maleate | [no description available] | medium | 1 | 0 | maleate salt | antidepressant |
isotretinoin | [no description available] | medium | 1 | 0 | retinoic acid | antineoplastic agent; keratolytic drug; teratogenic agent |
xylometazoline hydrochloride | [no description available] | medium | 1 | 0 | | |
flunarizine hydrochloride | [no description available] | medium | 1 | 0 | diarylmethane | |
ketotifen fumarate | [no description available] | medium | 1 | 0 | organoammonium salt | anti-asthmatic drug; H1-receptor antagonist |
cis-flupenthixol dihydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | geroprotector |
n-arachidonylglycine | [no description available] | medium | 1 | 0 | fatty amide; N-acylglycine | |
n-oleoylethanolamine | [no description available] | medium | 1 | 0 | endocannabinoid; N-(long-chain-acyl)ethanolamine; N-acylethanolamine 18:1 | EC 3.5.1.23 (ceramidase) inhibitor; geroprotector; PPARalpha agonist |
cyclosporine | [no description available] | medium | 3 | 0 | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
phenoxybenzamine hydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
phenylephrine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
mepyramine maleate | [no description available] | medium | 1 | 0 | | |
brefeldin a | [no description available] | medium | 1 | 0 | macrolide antibiotic | Penicillium metabolite |
fenretinide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; retinoid | antineoplastic agent; antioxidant |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | [no description available] | medium | 1 | 0 | benzoic acids; naphthalenes; retinoid | antineoplastic agent; retinoic acid receptor agonist; teratogenic agent |
l-2-(carboxypropyl)glycine | [no description available] | medium | 1 | 0 | | |
4-aminocrotonic acid | [no description available] | medium | 1 | 0 | | |
denopamine | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
l 655,708 | [no description available] | medium | 1 | 0 | | |
ro 41-1049 | [no description available] | medium | 1 | 0 | | |
sb 200646a | [no description available] | medium | 1 | 0 | | |
seglitide | [no description available] | medium | 1 | 0 | | |
sib 1893 | [no description available] | medium | 1 | 0 | | |
su 6656 | [no description available] | medium | 1 | 0 | | |
tyrphostin ag 555 | [no description available] | medium | 1 | 0 | | |
tyrphostin ag-494 | [no description available] | medium | 1 | 0 | | |
tyrphostin b44 | [no description available] | medium | 1 | 0 | | |
ag-490 | [no description available] | medium | 1 | 0 | catechols; enamide; monocarboxylic acid amide; nitrile; secondary carboxamide | anti-inflammatory agent; antioxidant; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector; STAT3 inhibitor |
ag 112 | [no description available] | medium | 1 | 0 | | |
ag 183 | [no description available] | medium | 1 | 0 | | |
semaxinib | [no description available] | medium | 1 | 0 | olefinic compound; oxindoles; pyrroles | angiogenesis modulating agent; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; vascular endothelial growth factor receptor antagonist |
8-(3-chlorostyryl)caffeine | [no description available] | medium | 1 | 0 | monochlorobenzenes; trimethylxanthine | adenosine A2A receptor antagonist; EC 1.4.3.4 (monoamine oxidase) inhibitor |
bay 11-7085 | [no description available] | medium | 1 | 0 | benzenes; nitrile; sulfone | anti-inflammatory agent; antibacterial agent; antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.11.10 (IkappaB kinase) inhibitor; ferroptosis inducer; NF-kappaB inhibitor |
molsidomine | [no description available] | medium | 1 | 0 | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent |
diamide | [no description available] | medium | 1 | 0 | 1,1'-azobis(N,N-dimethylformamide) | |
nomifensine maleate | [no description available] | medium | 1 | 0 | | |
nalbuphine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
isoalloxazine | [no description available] | medium | 1 | 0 | benzo[g]pteridine-2,4-dione | |
vinblastine sulfate | [no description available] | medium | 1 | 0 | | |
n-methylscopolamine bromide | [no description available] | medium | 1 | 0 | | |
dextromethorphan hydrobromide | [no description available] | medium | 1 | 0 | hydrate; hydrobromide | |
naloxone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
s-trans,trans-farnesylthiosalicylic acid | [no description available] | medium | 1 | 0 | sesquiterpenoid | |
sulindac sulfone | [no description available] | medium | 1 | 0 | monocarboxylic acid; organofluorine compound; sulfone | apoptosis inducer; cyclooxygenase 2 inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor |
naltrexone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
guanabenz acetate | [no description available] | medium | 1 | 0 | dichlorobenzene | geroprotector |
nylidrin hydrochloride | [no description available] | medium | 1 | 0 | alkylbenzene | |
triprolidine hydrochloride anhydrous | [no description available] | medium | 1 | 0 | hydrochloride | H1-receptor antagonist |
famotidine | [no description available] | medium | 2 | 0 | 1,3-thiazoles; guanidines; sulfonamide | anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
fenoterol | [no description available] | medium | 1 | 0 | hydrobromide | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent |
tiapridex | [no description available] | medium | 1 | 0 | benzamides | |
quipazine maleate | [no description available] | medium | 1 | 0 | | |
n-(2-aminoethyl)-4-chlorobenzamide hydrochloride | [no description available] | medium | 1 | 0 | | |
tulobuterol hydrochloride | [no description available] | medium | 1 | 0 | organic molecular entity | |
hp 029 | [no description available] | medium | 1 | 0 | | |
n,n,n-trimethyl-1-(4-stilbenoxy)-2-propylammonium iodide | [no description available] | medium | 1 | 0 | | |
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one | [no description available] | medium | 1 | 0 | naphthalenes | |
nf023 | [no description available] | medium | 1 | 0 | | |
nf 449 | [no description available] | medium | 1 | 0 | | |
7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine | [no description available] | medium | 1 | 0 | | |
gr 46611 | [no description available] | medium | 1 | 0 | | |
diacetylmonoxime | [no description available] | medium | 1 | 0 | | |
homatropine hydrobromide, (endo-(+-)-isomer) | [no description available] | medium | 1 | 0 | | |
vancomycin hydrochloride | [no description available] | medium | 1 | 0 | | |
moxisylyte hydrochloride | [no description available] | medium | 1 | 0 | monoterpenoid | |
dizocilpine maleate | [no description available] | medium | 2 | 0 | maleate salt; tetracyclic antidepressant | anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist |
beta-aminopropionitrile fumarate | [no description available] | medium | 1 | 0 | | |
flupirtine | [no description available] | medium | 1 | 0 | | |
zimelidine hydrochloride | [no description available] | medium | 1 | 0 | | |
pregna-4,17-diene-3,16-dione, (17z)-isomer | [no description available] | medium | 1 | 0 | | |
su 4312 | [no description available] | medium | 1 | 0 | | |
gw 1929 | [no description available] | medium | 1 | 0 | benzophenones | |
protriptyline hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant |
n(4)-chloroacetylcytosine arabinoside | [no description available] | medium | 1 | 0 | | |
n-(3-(cyclohexylidene-(1h-imidazol-4-ylmethyl))phenyl)ethanesulfonamide | [no description available] | medium | 1 | 0 | | |
n-(4-amino-2-chlorophenyl)phthalimide | [no description available] | medium | 1 | 0 | | |
cb 34 | [no description available] | medium | 1 | 0 | | |
b 43 | [no description available] | medium | 1 | 0 | aromatic amine; aromatic ether; cyclopentanes; primary amino compound; pyrrolopyrimidine | EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector |
(8R)-7-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol | [no description available] | medium | 1 | 0 | aporphine alkaloid | |
(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol | [no description available] | medium | 1 | 0 | aporphine alkaloid | |
3-(6-chloro-3-pyridazinyl)-3,8-diazabicyclo(3.2.1)octane | [no description available] | medium | 1 | 0 | | |
2-(3,3-diphenylpropylamino)acetamide | [no description available] | medium | 1 | 0 | diarylmethane | |
4-(2-(phenylsulfonylamino)ethylthio)-2,6-difluorophenoxyacetamide | [no description available] | medium | 1 | 0 | | |
gw2974 | [no description available] | medium | 1 | 0 | pyridopyrimidine | |
l 162313 | [no description available] | medium | 1 | 0 | | |
l-165041 | [no description available] | medium | 1 | 0 | aromatic ketone | |
mrs 1754 | [no description available] | medium | 1 | 0 | oxopurine | |
s-nitroso-n-acetylpenicillamine | [no description available] | medium | 1 | 0 | nitroso compound; nitrosothio compound | nitric oxide donor; vasodilator agent |
pd 404182 | [no description available] | medium | 1 | 0 | | |
sb 222200 | [no description available] | medium | 1 | 0 | quinolines | |
dantrolene sodium | [no description available] | medium | 1 | 0 | | |
cr 2945 | [no description available] | medium | 1 | 0 | | |
sb 218795 | [no description available] | medium | 1 | 0 | quinolines | |
dihydroceramide | [no description available] | medium | 1 | 0 | N-acylsphinganine | |
epinephrine bitartrate | [no description available] | medium | 1 | 0 | | |
bicuculline methobromide | [no description available] | medium | 1 | 0 | | |
butylscopolammonium bromide | [no description available] | medium | 1 | 0 | | |
butaclamol hydrochloride | [no description available] | medium | 1 | 0 | | |
a 38503 | [no description available] | medium | 1 | 0 | | |
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide | [no description available] | medium | 1 | 0 | | |
sk&f 89976-a | [no description available] | medium | 1 | 0 | | |
cv 1808 | [no description available] | medium | 1 | 0 | purine nucleoside | |
fluvoxamine maleate | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes | |
naloxone benzoylhydrazone | [no description available] | medium | 1 | 0 | | |
2-methyl-6-(phenylethynyl)pyridine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anxiolytic drug; metabotropic glutamate receptor antagonist |
amiprilose | [no description available] | medium | 1 | 0 | | |
(R)-fluoxetine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant; serotonin uptake inhibitor |
desmethylselegiline hydrochloride | [no description available] | medium | 1 | 0 | | |
3-morpholino-sydnonimine monohydrochloride | [no description available] | medium | 1 | 0 | | |
t 1032 | [no description available] | medium | 1 | 0 | | |
qx-314 bromide | [no description available] | medium | 1 | 0 | | |
(S)-fluoxetine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant; serotonin uptake inhibitor |
sr 59230a | [no description available] | medium | 1 | 0 | | |
u 74389g | [no description available] | medium | 1 | 0 | | |
1-(2-methoxyphenyl)piperazine hydrochloride | [no description available] | medium | 1 | 0 | | |
y 27632, dihydrochloride, (4(r)-trans)-isomer | [no description available] | medium | 1 | 0 | | |
noscapine hydrochloride | [no description available] | medium | 1 | 0 | | |
a 77636 | [no description available] | medium | 1 | 0 | hydrochloride | antiparkinson drug; dopamine agonist |
cgp 20712a | [no description available] | medium | 1 | 0 | | |
levodopa methyl ester hydrochloride | [no description available] | medium | 1 | 0 | | |
benalfocin hydrochloride | [no description available] | medium | 1 | 0 | | |
lu 19005 | [no description available] | medium | 1 | 0 | | |
benoxathian hydrochloride | [no description available] | medium | 1 | 0 | | |
((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid, (+)-isomer | [no description available] | medium | 1 | 0 | | |
n-cyclopropyl adenosine-5'-carboxamide | [no description available] | medium | 1 | 0 | | |
cefotaxime sodium | [no description available] | medium | 1 | 0 | organic sodium salt | |
calpain inhibitor iii | [no description available] | medium | 1 | 0 | | |
GR 127935 hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | serotonergic antagonist |
mrs 1845 | [no description available] | medium | 1 | 0 | | |
1-aminocyclopropane-1-carboxylic acid hydrochloride | [no description available] | medium | 1 | 0 | | |
alaproclate hydrochloride | [no description available] | medium | 1 | 0 | | |
ubenimex | [no description available] | medium | 1 | 0 | peptide | |
3-chloroalanine hydrochloride, (l-ala)-isomer | [no description available] | medium | 1 | 0 | | |
dsp 4 hydrochloride | [no description available] | medium | 1 | 0 | | |
calcimycin | [no description available] | medium | 1 | 0 | benzoxazole | |
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzodioxan hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | alpha-adrenergic antagonist |
2-cyclooctyl-2-hydroxyethylamine hydrochloride | [no description available] | medium | 1 | 0 | | |
cirazoline monohydrochloride | [no description available] | medium | 1 | 0 | | |
adtn | [no description available] | medium | 1 | 0 | | |
apocodeine hydrochloride, (r)-isomer | [no description available] | medium | 1 | 0 | | |
Dihydro-beta-erythroidine hydrobromide | [no description available] | medium | 1 | 0 | indoles | |
lilly 78335 | [no description available] | medium | 1 | 0 | | |
efaroxan hydrochloride | [no description available] | medium | 1 | 0 | | |
fenoldopam hydrobromide | [no description available] | medium | 1 | 0 | | |
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | dopamine uptake inhibitor |
guvacine hydrochloride | [no description available] | medium | 1 | 0 | | |
7-hydroxy-2-n,n-dipropylaminotetralin hydrobromide | [no description available] | medium | 1 | 0 | | |
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide, (r)-isomer, | [no description available] | medium | 1 | 0 | organic molecular entity | |
1-(2-(4-(4-fluoro-benzoyl)-piperidin-1-yl)-ethyl)-3,3-dimethyl-1,2-dihydro-indol-2-one | [no description available] | medium | 1 | 0 | hydrochloride | receptor modulator; serotonergic antagonist |
4-iodoclonidine | [no description available] | medium | 1 | 0 | | |
4-methylpyrazole monohydrochloride | [no description available] | medium | 1 | 0 | | |
tele-methylhistamine | [no description available] | medium | 1 | 0 | | |
alpha-methyltyrosine methyl ester, monohydrochloride | [no description available] | medium | 1 | 0 | | |
octoclothepine maleate | [no description available] | medium | 1 | 0 | | |
2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin hydrochloride | [no description available] | medium | 1 | 0 | | |
du 24565 | [no description available] | medium | 1 | 0 | | |
2-methoxyidazoxan hydrochloride | [no description available] | medium | 1 | 0 | | |
ro 25-6981 | [no description available] | medium | 1 | 0 | | |
sk&f 77434 | [no description available] | medium | 1 | 0 | hydrobromide | dopamine agonist; prodrug |
3-[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-yl]-1,1-diethylurea | [no description available] | medium | 1 | 0 | organic heterotetracyclic compound; organonitrogen heterocyclic compound | |
demethylcantharidin | [no description available] | medium | 1 | 0 | | |
atropine sulfate | [no description available] | medium | 1 | 0 | | |
1-deoxynojirimycin hydrochloride | [no description available] | medium | 1 | 0 | | |
win 62577 | [no description available] | medium | 1 | 0 | | |
quinine sulfate | [no description available] | medium | 1 | 0 | hydrate | |
quercetin | [no description available] | medium | 1 | 0 | | |
rv 538, (r-(r*,r*))-isomer | [no description available] | medium | 1 | 0 | | |
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1s-cis)-isomer | [no description available] | medium | 1 | 0 | | |
valproate sodium | [no description available] | medium | 1 | 0 | organic sodium salt | geroprotector |
u 63557a | [no description available] | medium | 1 | 0 | | |
taurocholic acid, monosodium salt | [no description available] | medium | 1 | 0 | bile salt | |
cefmetazole sodium | [no description available] | medium | 1 | 0 | organic sodium salt | antimicrobial agent |
fusidate sodium | [no description available] | medium | 1 | 0 | | |
cephapirin sodium | [no description available] | medium | 1 | 0 | cephalosporin; organic sodium salt | antibacterial drug |
sodium cephalothin | [no description available] | medium | 1 | 0 | organic sodium salt | |
cefazolin sodium | [no description available] | medium | 1 | 0 | organic sodium salt | |
5-hydroxydecanoic acid, monosodium salt | [no description available] | medium | 1 | 0 | | |
ro13-9904 | [no description available] | medium | 1 | 0 | | |
phenytoin sodium | [no description available] | medium | 1 | 0 | | |
cr 1409 | [no description available] | medium | 1 | 0 | | |
cortisol succinate, sodium salt | [no description available] | medium | 1 | 0 | organic molecular entity | |
piroxicam | [no description available] | medium | 1 | 0 | benzothiazine; monocarboxylic acid amide; pyridines | analgesic; antirheumatic drug; cyclooxygenase 1 inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
lfm a13 | [no description available] | medium | 1 | 0 | aromatic amide; dibromobenzene; enamide; enol; nitrile; secondary carboxamide | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 2.7.11.21 (polo kinase) inhibitor; geroprotector; platelet aggregation inhibitor |
l 701324 | [no description available] | medium | 1 | 0 | quinolines | |
hispidin | [no description available] | medium | 1 | 0 | 2-pyranones; catechols | antioxidant; EC 2.7.11.13 (protein kinase C) inhibitor; fungal metabolite |
minocycline hydrochloride | [no description available] | medium | 1 | 0 | | |
demeclocycline hydrochloride | [no description available] | medium | 1 | 0 | | |
acyclovir | [no description available] | medium | 3 | 0 | 2-aminopurines; oxopurine | antimetabolite; antiviral drug |
sepiapterin | [no description available] | medium | 1 | 0 | sepiapterin | |
isoxanthopterin | [no description available] | medium | 1 | 0 | dihydroxypteridine | |
clozapine | [no description available] | medium | 3 | 0 | benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound | adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic |
ganciclovir | [no description available] | medium | 3 | 0 | 2-aminopurines; oxopurine | antiinfective agent; antiviral drug |
zaprinast | [no description available] | medium | 1 | 0 | triazolopyrimidines | |
allopurinol | [no description available] | medium | 3 | 0 | nucleobase analogue; organic heterobicyclic compound | antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger |
thiolactomycin | [no description available] | medium | 1 | 0 | | |
2,4-diaminohypoxanthine | [no description available] | medium | 1 | 0 | hydroxypyrimidine | |
quazinone | [no description available] | medium | 1 | 0 | | |
8-bromocyclic gmp, sodium salt | [no description available] | medium | 1 | 0 | organic sodium salt | muscle relaxant; protein kinase G agonist |
ag-879 | [no description available] | medium | 1 | 0 | | |
1-(3-chlorophenyl)piperazine | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-arylpiperazine | drug metabolite; environmental contaminant; serotonergic agonist; xenobiotic |
tacrine | [no description available] | medium | 2 | 0 | acridines; aromatic amine | EC 3.1.1.7 (acetylcholinesterase) inhibitor |
acebutolol | [no description available] | medium | 2 | 0 | aromatic amide; ethanolamines; ether; monocarboxylic acid amide; propanolamine; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympathomimetic agent |
acetaminophen | [no description available] | medium | 2 | 0 | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
alfuzosin | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; quinazolines; tetrahydrofuranol | alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent |
alosetron | [no description available] | medium | 1 | 0 | imidazoles; pyridoindole | antiemetic; gastrointestinal drug; serotonergic antagonist |
alprazolam | [no description available] | medium | 2 | 0 | organochlorine compound; triazolobenzodiazepine | anticonvulsant; anxiolytic drug; GABA agonist; muscle relaxant; sedative; xenobiotic |
alprenolol | [no description available] | medium | 3 | 0 | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
amantadine | [no description available] | medium | 2 | 0 | adamantanes; primary aliphatic amine | analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic |
diatrizoic acid | [no description available] | medium | 1 | 0 | acetamides; benzoic acids; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic |
amiodarone | [no description available] | medium | 2 | 0 | 1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound | cardiovascular drug |
amitriptyline | [no description available] | medium | 2 | 0 | carbotricyclic compound; tertiary amine | adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic |
amlodipine | [no description available] | medium | 2 | 0 | dihydropyridine; ethyl ester; methyl ester; monochlorobenzenes; primary amino compound | antihypertensive agent; calcium channel blocker; vasodilator agent |
amsacrine | [no description available] | medium | 1 | 0 | acridines; aromatic ether; sulfonamide | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
antipyrine | [no description available] | medium | 2 | 0 | pyrazolone | antipyretic; cyclooxygenase 3 inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
azelastine | [no description available] | medium | 1 | 0 | monochlorobenzenes; phthalazines; tertiary amino compound | anti-allergic agent; anti-asthmatic drug; bronchodilator agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; H1-receptor antagonist; platelet aggregation inhibitor |
betaxolol | [no description available] | medium | 2 | 0 | propanolamine | antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
bevantolol | [no description available] | medium | 1 | 0 | propanolamine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; calcium channel blocker |
biperiden | [no description available] | medium | 2 | 0 | piperidines; tertiary alcohol; tertiary amino compound | antidote to sarin poisoning; antidyskinesia agent; antiparkinson drug; muscarinic antagonist; parasympatholytic |
bisoprolol | [no description available] | medium | 2 | 0 | secondary alcohol; secondary amine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
bromazepam | [no description available] | medium | 2 | 0 | organic molecular entity | |
bromopride | [no description available] | medium | 1 | 0 | benzamides | |
brotizolam | [no description available] | medium | 1 | 0 | organic molecular entity | |
buflomedil | [no description available] | medium | 2 | 0 | aromatic ketone | |
bunazosin | [no description available] | medium | 1 | 0 | quinazolines | |
bupivacaine | [no description available] | medium | 2 | 0 | aromatic amide; piperidinecarboxamide; tertiary amino compound | |
busulfan | [no description available] | medium | 2 | 0 | methanesulfonate ester | alkylating agent; antineoplastic agent; carcinogenic agent; insect sterilant; teratogenic agent |
verapamil | [no description available] | medium | 4 | 0 | aromatic ether; nitrile; polyether; tertiary amino compound | |
metrizoate | [no description available] | medium | 1 | 0 | monocarboxylic acid | radioopaque medium |
carvedilol | [no description available] | medium | 2 | 0 | carbazoles; secondary alcohol; secondary amino compound | alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent |
chlordiazepoxide | [no description available] | medium | 2 | 0 | benzodiazepine | |
chloroquine | [no description available] | medium | 4 | 0 | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug |
chlorpheniramine | [no description available] | medium | 2 | 0 | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor |
chlorpromazine | [no description available] | medium | 2 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
chlorthalidone | [no description available] | medium | 2 | 0 | isoindoles; monochlorobenzenes; sulfonamide | |
cifenline | [no description available] | medium | 2 | 0 | diarylmethane | |
ciprofloxacin | [no description available] | medium | 2 | 0 | aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion | antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic |
citalopram | [no description available] | medium | 2 | 0 | 2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound | |
clomipramine | [no description available] | medium | 1 | 0 | dibenzoazepine | anticoronaviral agent; antidepressant; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; serotonergic antagonist; serotonergic drug; serotonin uptake inhibitor |
clonazepam | [no description available] | medium | 3 | 0 | 1,4-benzodiazepinone; monochlorobenzenes | anticonvulsant; anxiolytic drug; GABA modulator |
clonidine | [no description available] | medium | 1 | 0 | clonidine; imidazoline | |
chlorazepate | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone | anticonvulsant; anxiolytic drug; GABA modulator; prodrug |
dapsone | [no description available] | medium | 2 | 0 | substituted aniline; sulfone | anti-inflammatory drug; antiinfective agent; antimalarial; leprostatic drug |
desipramine | [no description available] | medium | 4 | 0 | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor |
nordazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative |
amphetamine | [no description available] | medium | 1 | 0 | primary amine | |
diazepam | [no description available] | medium | 4 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
diazepam | [no description available] | medium | 4 | 1 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
diclofenac | [no description available] | medium | 2 | 0 | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
diflunisal | [no description available] | medium | 1 | 0 | monohydroxybenzoic acid; organofluorine compound | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
valproic acid | [no description available] | medium | 4 | 0 | branched-chain fatty acid; branched-chain saturated fatty acid | anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent |
doxapram | [no description available] | medium | 2 | 0 | morpholines; pyrrolidin-2-ones | central nervous system stimulant |
doxazosin | [no description available] | medium | 1 | 0 | aromatic amine; benzodioxine; monocarboxylic acid amide; N-acylpiperazine; N-arylpiperazine; quinazolines | alpha-adrenergic antagonist; antihyperplasia drug; antihypertensive agent; antineoplastic agent; vasodilator agent |
doxepin | [no description available] | medium | 1 | 0 | dibenzooxepine; tertiary amino compound | antidepressant |
dyphylline | [no description available] | medium | 2 | 0 | oxopurine; propane-1,2-diols | bronchodilator agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; muscle relaxant; vasodilator agent |
enoxacin | [no description available] | medium | 1 | 0 | 1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
ethacrynic acid | [no description available] | medium | 1 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
etilefrine | [no description available] | medium | 2 | 0 | phenols | |
berotek | [no description available] | medium | 1 | 0 | resorcinols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent; tocolytic agent |
fenspiride | [no description available] | medium | 2 | 0 | azaspiro compound | |
fentanyl | [no description available] | medium | 1 | 0 | anilide; monocarboxylic acid amide; piperidines | adjuvant; anaesthesia adjuvant; anaesthetic; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic |
flecainide | [no description available] | medium | 2 | 0 | aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines | anti-arrhythmia drug |
fleroxacin | [no description available] | medium | 2 | 0 | difluorobenzene; fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; quinolines | antibacterial drug; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
fluconazole | [no description available] | medium | 2 | 0 | conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug | environmental contaminant; P450 inhibitor; xenobiotic |
flucytosine | [no description available] | medium | 2 | 0 | aminopyrimidine; nucleoside analogue; organofluorine compound; pyrimidine antifungal drug; pyrimidone | prodrug |
flunitrazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative |
fluorescite | [no description available] | medium | 1 | 0 | benzoic acids; cyclic ketone; hydroxy monocarboxylic acid; organic heterotricyclic compound; phenols; xanthene dye | fluorescent dye; radioopaque medium |
foscarnet | [no description available] | medium | 2 | 0 | carboxylic acid; one-carbon compound; phosphonic acids | antiviral drug; geroprotector; HIV-1 reverse transcriptase inhibitor; sodium-dependent Pi-transporter inhibitor |
glimepiride | [no description available] | medium | 2 | 0 | sulfonamide | |
granisetron | [no description available] | medium | 2 | 0 | aromatic amide; indazoles | |
guanfacine | [no description available] | medium | 2 | 0 | acetamides | |
hexobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
hydralazine | [no description available] | medium | 1 | 0 | azaarene; hydrazines; ortho-fused heteroarene; phthalazines | antihypertensive agent; vasodilator agent |
hydroflumethiazide | [no description available] | medium | 2 | 0 | benzothiadiazine; thiazide | antihypertensive agent; diuretic |
hydroxychloroquine | [no description available] | medium | 1 | 0 | aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug |
hypericin | [no description available] | medium | 1 | 0 | | |
lidocaine | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid amide; tertiary amino compound | anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic |
ifosfamide | [no description available] | medium | 2 | 0 | ifosfamides | alkylating agent; antineoplastic agent; environmental contaminant; immunosuppressive agent; xenobiotic |
imipramine | [no description available] | medium | 1 | 0 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
amrinone | [no description available] | medium | 1 | 0 | bipyridines | EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
iohexol | [no description available] | medium | 1 | 0 | benzenedicarboxamide; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic |
iopromide | [no description available] | medium | 1 | 0 | dicarboxylic acid diamide; organoiodine compound | environmental contaminant; nephrotoxic agent; radioopaque medium; xenobiotic |
iothalamic acid | [no description available] | medium | 1 | 0 | organic molecular entity | |
avapro | [no description available] | medium | 1 | 0 | azaspiro compound; biphenylyltetrazole | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
isoniazid | [no description available] | medium | 1 | 0 | carbohydrazide | antitubercular agent; drug allergen |
isoproterenol | [no description available] | medium | 1 | 0 | catechols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent |
isradipine | [no description available] | medium | 1 | 0 | benzoxadiazole; dihydropyridine; isopropyl ester; methyl ester | |
itraconazole | [no description available] | medium | 2 | 0 | piperazines | |
ketamine | [no description available] | medium | 1 | 0 | cyclohexanones; monochlorobenzenes; secondary amino compound | analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic |
ketanserin | [no description available] | medium | 2 | 0 | aromatic ketone; organofluorine compound; piperidines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; cardiovascular drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist |
ketorolac | [no description available] | medium | 2 | 0 | amino acid; aromatic ketone; monocarboxylic acid; pyrrolizines; racemate | analgesic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
labetalol | [no description available] | medium | 1 | 0 | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | |
letrozole | [no description available] | medium | 2 | 0 | nitrile; triazoles | antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor |
lorazepam | [no description available] | medium | 2 | 0 | benzodiazepine | |
losartan | [no description available] | medium | 2 | 0 | biphenylyltetrazole; imidazoles | angiotensin receptor antagonist; anti-arrhythmia drug; antihypertensive agent; endothelin receptor antagonist |
maprotiline | [no description available] | medium | 1 | 0 | anthracenes | |
mebendazole | [no description available] | medium | 2 | 0 | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator |
meperidine | [no description available] | medium | 1 | 0 | ethyl ester; piperidinecarboxylate ester; tertiary amino compound | antispasmodic drug; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic |
mepivacaine | [no description available] | medium | 1 | 0 | piperidinecarboxamide | drug allergen; local anaesthetic |
meprobamate | [no description available] | medium | 1 | 0 | organic molecular entity | |
mesalamine | [no description available] | medium | 1 | 0 | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
metformin | [no description available] | medium | 2 | 0 | guanidines | environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic |
methadone | [no description available] | medium | 2 | 0 | benzenes; diarylmethane; ketone; tertiary amino compound | |
methapyrilene | [no description available] | medium | 1 | 0 | ethylenediamine derivative | anti-allergic agent; carcinogenic agent; H1-receptor antagonist; sedative |
methylphenidate | [no description available] | medium | 2 | 0 | beta-amino acid ester; methyl ester; piperidines | |
metoclopramide | [no description available] | medium | 2 | 0 | benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound | antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic |
metoprolol | [no description available] | medium | 3 | 0 | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic |
metronidazole | [no description available] | medium | 2 | 0 | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic |
mexiletine | [no description available] | medium | 1 | 0 | aromatic ether; primary amino compound | anti-arrhythmia drug |
midazolam | [no description available] | medium | 2 | 0 | imidazobenzodiazepine; monofluorobenzenes; organochlorine compound | anticonvulsant; antineoplastic agent; anxiolytic drug; apoptosis inducer; central nervous system depressant; GABAA receptor agonist; general anaesthetic; muscle relaxant; sedative |
mirtazapine | [no description available] | medium | 2 | 0 | benzazepine; tetracyclic antidepressant | alpha-adrenergic antagonist; anxiolytic drug; H1-receptor antagonist; histamine antagonist; oneirogen; serotonergic antagonist |
moclobemide | [no description available] | medium | 4 | 0 | benzamides; monochlorobenzenes; morpholines | antidepressant; environmental contaminant; xenobiotic |
acecainide | [no description available] | medium | 1 | 0 | acetamides; benzamides | anti-arrhythmia drug |
naratriptan | [no description available] | medium | 2 | 0 | heteroarylpiperidine; sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
nefazodone | [no description available] | medium | 2 | 0 | aromatic ether; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazoles | alpha-adrenergic antagonist; analgesic; antidepressant; serotonergic antagonist; serotonin uptake inhibitor |
nefopam | [no description available] | medium | 1 | 0 | benzoxazocine; tertiary amino compound | |
nevirapine | [no description available] | medium | 2 | 0 | cyclopropanes; dipyridodiazepine | antiviral drug; HIV-1 reverse transcriptase inhibitor |
nicardipine | [no description available] | medium | 2 | 0 | benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound | |
nisoldipine | [no description available] | medium | 2 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | |
nitrazepam | [no description available] | medium | 2 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative |
nizatidine | [no description available] | medium | 2 | 0 | 1,3-thiazoles; C-nitro compound; carboxamidine; organic sulfide; tertiary amino compound | anti-ulcer drug; cholinergic drug; H2-receptor antagonist |
nomifensine | [no description available] | medium | 2 | 0 | isoquinolines | dopamine uptake inhibitor |
nortriptyline | [no description available] | medium | 2 | 0 | organic tricyclic compound; secondary amine | adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite |
omeprazole | [no description available] | medium | 2 | 0 | aromatic ether; benzimidazoles; pyridines; sulfoxide | |
ondansetron | [no description available] | medium | 2 | 0 | carbazoles | |
oxazepam | [no description available] | medium | 2 | 0 | 1,4-benzodiazepinone; organochlorine compound | anxiolytic drug; environmental contaminant; xenobiotic |
oxybutynin | [no description available] | medium | 1 | 0 | acetylenic compound; carboxylic ester; racemate; tertiary alcohol; tertiary amino compound | antispasmodic drug; calcium channel blocker; local anaesthetic; muscarinic antagonist; muscle relaxant; parasympatholytic |
pamidronate | [no description available] | medium | 1 | 0 | phosphonoacetic acid | |
pantoprazole | [no description available] | medium | 2 | 0 | aromatic ether; benzimidazoles; organofluorine compound; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; environmental contaminant; xenobiotic |
papaverine | [no description available] | medium | 2 | 0 | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
pentobarbital | [no description available] | medium | 1 | 0 | barbiturates | GABAA receptor agonist |
phenacetin | [no description available] | medium | 1 | 0 | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug |
phenobarbital | [no description available] | medium | 3 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
moxonidine | [no description available] | medium | 2 | 0 | organohalogen compound; pyrimidines | |
pimobendan | [no description available] | medium | 1 | 0 | benzimidazoles; pyridazinone | cardiotonic drug; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |
piretanide | [no description available] | medium | 1 | 0 | aromatic ether | |
prazosin | [no description available] | medium | 2 | 0 | aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
prilocaine | [no description available] | medium | 1 | 0 | amino acid amide; monocarboxylic acid amide | anticonvulsant; local anaesthetic |
primaquine | [no description available] | medium | 1 | 0 | aminoquinoline; aromatic ether; N-substituted diamine | antimalarial |
probenecid | [no description available] | medium | 2 | 0 | benzoic acids; sulfonamide | uricosuric drug |
procainamide | [no description available] | medium | 2 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
prochlorperazine | [no description available] | medium | 1 | 0 | N-alkylpiperazine; N-methylpiperazine; organochlorine compound; phenothiazines | alpha-adrenergic antagonist; antiemetic; cholinergic antagonist; dopamine receptor D2 antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic |
procyclidine | [no description available] | medium | 2 | 0 | pyrrolidines; tertiary alcohol | antidyskinesia agent; antiparkinson drug; muscarinic antagonist |
promazine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amine | antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist |
promethazine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amine | anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative |
propafenone | [no description available] | medium | 3 | 0 | aromatic ketone; secondary alcohol; secondary amino compound | anti-arrhythmia drug |
propranolol | [no description available] | medium | 2 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
pyridostigmine | [no description available] | medium | 2 | 0 | pyridinium ion | |
pyrimethamine | [no description available] | medium | 3 | 0 | aminopyrimidine; monochlorobenzenes | antimalarial; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor |
rabeprazole | [no description available] | medium | 2 | 0 | benzimidazoles; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
ranitidine | [no description available] | medium | 2 | 0 | aralkylamine | |
rizatriptan | [no description available] | medium | 1 | 0 | tryptamines | anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
sulfadiazine | [no description available] | medium | 2 | 0 | pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
risedronic acid | [no description available] | medium | 2 | 0 | pyridines | |
sotalol | [no description available] | medium | 2 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
imatinib | [no description available] | medium | 1 | 0 | aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines | antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor |
vorinostat | [no description available] | medium | 1 | 0 | dicarboxylic acid diamide; hydroxamic acid | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
sulfamethoxazole | [no description available] | medium | 2 | 0 | isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic |
sulfinpyrazone | [no description available] | medium | 2 | 0 | pyrazolidines; sulfoxide | uricosuric drug |
sulfisoxazole | [no description available] | medium | 2 | 0 | isoxazoles; sulfonamide antibiotic; sulfonamide | antibacterial drug; drug allergen |
sumatriptan | [no description available] | medium | 2 | 0 | sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
suprofen | [no description available] | medium | 2 | 0 | aromatic ketone; monocarboxylic acid; thiophenes | antirheumatic drug; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug |
suramin | [no description available] | medium | 2 | 0 | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
gatifloxacin | [no description available] | medium | 2 | 0 | N-arylpiperazine; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antiinfective agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
temozolomide | [no description available] | medium | 1 | 0 | imidazotetrazine; monocarboxylic acid amide; triazene derivative | alkylating agent; antineoplastic agent; prodrug |
terazosin | [no description available] | medium | 2 | 0 | furans; piperazines; primary amino compound; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent |
terbutaline | [no description available] | medium | 2 | 0 | phenylethanolamines; resorcinols | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; sympathomimetic agent; tocolytic agent |
thiotepa | [no description available] | medium | 1 | 0 | aziridines | |
tinidazole | [no description available] | medium | 2 | 0 | imidazoles | antiamoebic agent; antibacterial drug; antiparasitic agent; antiprotozoal drug |
tizanidine | [no description available] | medium | 2 | 0 | benzothiadiazole; imidazoles | alpha-adrenergic agonist; muscle relaxant |
ultram | [no description available] | medium | 2 | 0 | aromatic ether; tertiary alcohol; tertiary amino compound | |
tranexamic acid | [no description available] | medium | 1 | 0 | amino acid | |
trazodone | [no description available] | medium | 2 | 0 | monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazolopyridine | adrenergic antagonist; antidepressant; anxiolytic drug; H1-receptor antagonist; sedative; serotonin uptake inhibitor |
triazolam | [no description available] | medium | 2 | 0 | triazolobenzodiazepine | sedative |
trimetrexate | [no description available] | medium | 1 | 0 | | |
trimipramine | [no description available] | medium | 1 | 0 | dibenzoazepine; tertiary amino compound | antidepressant; environmental contaminant; xenobiotic |
urapidil | [no description available] | medium | 2 | 0 | piperazines | |
venlafaxine | [no description available] | medium | 2 | 0 | cyclohexanols; monomethoxybenzene; tertiary alcohol; tertiary amino compound | adrenergic uptake inhibitor; analgesic; antidepressant; dopamine uptake inhibitor; environmental contaminant; serotonin uptake inhibitor; xenobiotic |
viloxazine | [no description available] | medium | 1 | 0 | aromatic ether | |
zaleplon | [no description available] | medium | 2 | 0 | nitrile; pyrazolopyrimidine | anticonvulsant; anxiolytic drug; central nervous system depressant; sedative |
zolpidem | [no description available] | medium | 2 | 0 | imidazopyridine | central nervous system depressant; GABA agonist; sedative |
zopiclone | [no description available] | medium | 2 | 0 | monochloropyridine; pyrrolopyrazine | central nervous system depressant; sedative |
prednisolone | [no description available] | medium | 2 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | adrenergic agent; anti-inflammatory drug; antineoplastic agent; drug metabolite; environmental contaminant; immunosuppressive agent; xenobiotic |
cephaloridine | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative | antibacterial drug |
prednisone | [no description available] | medium | 2 | 0 | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | adrenergic agent; anti-inflammatory drug; antineoplastic agent; immunosuppressive agent; prodrug |
penicillin g | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug; drug allergen; epitope |
chloramphenicol | [no description available] | medium | 2 | 0 | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
ethinyl estradiol | [no description available] | medium | 1 | 0 | 17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound | xenoestrogen |
cephalothin | [no description available] | medium | 1 | 0 | azabicycloalkene; beta-lactam antibiotic allergen; carboxylic acid; cephalosporin; semisynthetic derivative; thiophenes | antibacterial drug; antimicrobial agent |
kanamycin a | [no description available] | medium | 1 | 0 | kanamycins | bacterial metabolite |
methicillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
oxacillin | [no description available] | medium | 1 | 0 | penicillin | antibacterial agent; antibacterial drug |
ampicillin | [no description available] | medium | 2 | 0 | beta-lactam antibiotic; penicillin allergen; penicillin | antibacterial drug |
triamcinolone acetonide | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; cyclic ketal; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone | anti-allergic agent; anti-inflammatory drug |
phencyclidine | [no description available] | medium | 2 | 0 | benzenes; piperidines | anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug |
dichloroacetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid; organochlorine compound | astringent; marine metabolite |
methylprednisolone | [no description available] | medium | 1 | 0 | 6-methylprednisolone; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | adrenergic agent; anti-inflammatory drug; antiemetic; environmental contaminant; neuroprotective agent; xenobiotic |
penicillin v | [no description available] | medium | 2 | 0 | penicillin allergen; penicillin | |
isosorbide dinitrate | [no description available] | medium | 1 | 0 | glucitol derivative; nitrate ester | nitric oxide donor; vasodilator agent |
ergotamine | [no description available] | medium | 1 | 0 | peptide ergot alkaloid | alpha-adrenergic agonist; mycotoxin; non-narcotic analgesic; oxytocic; serotonergic agonist; vasoconstrictor agent |
nafcillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
methohexital | [no description available] | medium | 1 | 0 | acetylenic compound; barbiturates | drug allergen; intravenous anaesthetic |
pirinitramide | [no description available] | medium | 1 | 0 | nitrile | |
edrophonium bromide | [no description available] | medium | 1 | 0 | | |
galantamine | [no description available] | medium | 1 | 0 | benzazepine alkaloid fundamental parent; benzazepine alkaloid; organic heterotetracyclic compound; tertiary amino compound | antidote to curare poisoning; cholinergic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant metabolite |
dextropropoxyphene | [no description available] | medium | 1 | 0 | 1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate | mu-opioid receptor agonist; opioid analgesic |
ketobemidone | [no description available] | medium | 1 | 0 | piperidines | |
chlormethiazole | [no description available] | medium | 1 | 0 | thiazoles | |
methamphetamine | [no description available] | medium | 2 | 0 | amphetamines; secondary amine | central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic |
lithium carbonate | [no description available] | medium | 1 | 0 | carbonate salt; lithium salt | antimanic drug |
erythromycin | [no description available] | medium | 2 | 0 | cyclic ketone; erythromycin | |
levonorgestrel | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; terminal acetylenic compound | contraceptive drug; female contraceptive drug; progestin; synthetic oral contraceptive |
lormetazepam | [no description available] | medium | 2 | 0 | 1,4-benzodiazepinone; organochlorine compound | sedative |
ethambutol | [no description available] | medium | 1 | 0 | ethanolamines; ethylenediamine derivative | antitubercular agent; environmental contaminant; xenobiotic |
vancomycin | [no description available] | medium | 2 | 0 | glycopeptide | antibacterial drug; antimicrobial agent; bacterial metabolite |
metylperon | [no description available] | medium | 1 | 0 | aromatic ketone | |
spectinomycin | [no description available] | medium | 1 | 0 | cyclic acetal; cyclic hemiketal; cyclic ketone; pyranobenzodioxin; secondary alcohol; secondary amino compound | antibacterial drug; antimicrobial agent; bacterial metabolite |
dronabinol | [no description available] | medium | 1 | 0 | benzochromene; diterpenoid; phytocannabinoid; polyketide | cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic |
benperidol | [no description available] | medium | 1 | 0 | aromatic ketone | |
chlordesmethyldiazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
stavudine | [no description available] | medium | 1 | 0 | dihydrofuran; nucleoside analogue; organic molecular entity | antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
dicloxacillin | [no description available] | medium | 2 | 0 | dichlorobenzene; penicillin | antibacterial drug |
streptomycin | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; antibiotic fungicide; streptomycins | antibacterial drug; antifungal agrochemical; antimicrobial agent; antimicrobial drug; bacterial metabolite; protein synthesis inhibitor |
cladribine | [no description available] | medium | 1 | 0 | organochlorine compound; purine 2'-deoxyribonucleoside | antineoplastic agent; immunosuppressive agent |
carbenicillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
floxacillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
beclomethasone dipropionate | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid; chlorinated steroid; corticosteroid; enone; glucocorticoid; propanoate ester; steroid ester | anti-arrhythmia drug; anti-asthmatic drug; anti-inflammatory drug; prodrug |
olsalazine | [no description available] | medium | 2 | 0 | azobenzenes; dicarboxylic acid | non-steroidal anti-inflammatory drug; prodrug |
terodiline | [no description available] | medium | 2 | 0 | diarylmethane | |
1-(4-carboxyphenyl)-3,3-dimethyltriazene | [no description available] | medium | 1 | 0 | | |
metocurine iodide | [no description available] | medium | 1 | 0 | aromatic ether | |
apazone | [no description available] | medium | 1 | 0 | benzotriazines | non-steroidal anti-inflammatory drug; uricosuric drug |
selegiline | [no description available] | medium | 3 | 0 | selegiline; terminal acetylenic compound | geroprotector |
cephalexin | [no description available] | medium | 2 | 0 | beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative | antibacterial drug |
isosorbide-5-mononitrate | [no description available] | medium | 2 | 0 | glucitol derivative; nitrate ester | nitric oxide donor; vasodilator agent |
cephapirin | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug |
pregnanolone | [no description available] | medium | 1 | 0 | 3-hydroxy-5beta-pregnan-20-one; 3alpha-hydroxy steroid | human metabolite; intravenous anaesthetic; sedative |
du-21220 | [no description available] | medium | 1 | 0 | benzyl alcohols; polyphenol; secondary alcohol; secondary amino compound | |
ribostamycin | [no description available] | medium | 1 | 0 | amino cyclitol glycoside; aminoglycoside antibiotic | antibacterial drug; antimicrobial agent; metabolite |
cefazolin | [no description available] | medium | 2 | 0 | beta-lactam antibiotic allergen; cephalosporin; tetrazoles; thiadiazoles | antibacterial drug |
amoxicillin | [no description available] | medium | 2 | 0 | penicillin allergen; penicillin | antibacterial drug |
timolol | [no description available] | medium | 2 | 0 | timolol | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
indoramin | [no description available] | medium | 1 | 0 | tryptamines | |
toloxatone | [no description available] | medium | 1 | 0 | oxazolidinone; primary alcohol; toluenes | |
sisomicin | [no description available] | medium | 1 | 0 | amino cyclitol glycoside; aminoglycoside antibiotic; beta-L-arabinoside; monosaccharide derivative | |
amdinocillin | [no description available] | medium | 1 | 0 | penicillin | antibacterial drug; antiinfective agent |
tobramycin | [no description available] | medium | 1 | 0 | amino cyclitol glycoside | antibacterial agent; antimicrobial agent; toxin |
ticarcillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
trimazosin | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
adinazolam | [no description available] | medium | 2 | 0 | triazolobenzodiazepine | anticonvulsant; antidepressant; anxiolytic drug; sedative |
amikacin | [no description available] | medium | 1 | 0 | alpha-D-glucoside; amino cyclitol glycoside; aminoglycoside; carboxamide | antibacterial drug; antimicrobial agent; nephrotoxin |
tolamolol | [no description available] | medium | 1 | 0 | | |
tocainide | [no description available] | medium | 2 | 0 | monocarboxylic acid amide | anti-arrhythmia drug; local anaesthetic; sodium channel blocker |
sulbenicillin | [no description available] | medium | 1 | 0 | penicillin | |
sq-11725 | [no description available] | medium | 2 | 0 | | |
diltiazem | [no description available] | medium | 4 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
vecuronium bromide | [no description available] | medium | 1 | 0 | organic bromide salt; quaternary ammonium salt | muscle relaxant; neuromuscular agent; nicotinic antagonist |
meptazinol | [no description available] | medium | 1 | 0 | azepanes | |
sufentanil | [no description available] | medium | 2 | 0 | anilide; ether; piperidines; thiophenes | anaesthesia adjuvant; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic |
torsemide | [no description available] | medium | 2 | 0 | aminopyridine; N-sulfonylurea; secondary amino compound | antihypertensive agent; loop diuretic |
medroxalol | [no description available] | medium | 1 | 0 | salicylamides | |
epirubicin | [no description available] | medium | 1 | 0 | aminoglycoside; anthracycline antibiotic; anthracycline; deoxy hexoside; monosaccharide derivative; p-quinones; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | antimicrobial agent; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
cefmetazole | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug |
lorcainide | [no description available] | medium | 2 | 0 | acetamides | |
ceforanide | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug |
piperacillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
paroxetine | [no description available] | medium | 1 | 0 | aromatic ether; benzodioxoles; organofluorine compound; piperidines | antidepressant; anxiolytic drug; hepatotoxic agent; P450 inhibitor; serotonin uptake inhibitor |
cefoperazone | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug |
atracurium | [no description available] | medium | 1 | 0 | diester; quaternary ammonium ion | muscle relaxant; nicotinic antagonist |
moxalactam | [no description available] | medium | 1 | 0 | cephalosporin; oxacephem | antibacterial drug |
endralazine | [no description available] | medium | 1 | 0 | benzamides | |
cefadroxil anhydrous | [no description available] | medium | 2 | 0 | cephalosporin | antibacterial drug |
encainide | [no description available] | medium | 2 | 0 | benzamides; piperidines | anti-arrhythmia drug; sodium channel blocker |
pefloxacin | [no description available] | medium | 2 | 0 | fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; N-arylpiperazine; quinolone antibiotic; quinolone | antibacterial drug; antiinfective agent; DNA synthesis inhibitor |
alfentanil | [no description available] | medium | 2 | 0 | monocarboxylic acid amide; piperidines | central nervous system depressant; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic; peripheral nervous system drug |
cefotetan | [no description available] | medium | 1 | 0 | | |
recainam | [no description available] | medium | 2 | 0 | | |
lovastatin | [no description available] | medium | 2 | 0 | delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug |
flupirtine | [no description available] | medium | 2 | 0 | aminopyridine | |
idazoxan | [no description available] | medium | 2 | 0 | benzodioxine; imidazolines | alpha-adrenergic antagonist |
remoxipride | [no description available] | medium | 2 | 0 | dimethoxybenzene | |
pravastatin | [no description available] | medium | 2 | 0 | 3-hydroxy carboxylic acid; carbobicyclic compound; carboxylic ester; hydroxy monocarboxylic acid; secondary alcohol; statin (semi-synthetic) | anticholesteremic drug; environmental contaminant; metabolite; xenobiotic |
bambuterol | [no description available] | medium | 1 | 0 | carbamate ester; phenylethanolamines | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; prodrug; sympathomimetic agent; tocolytic agent |
trospectomycin | [no description available] | medium | 1 | 0 | dioxanes | |
finasteride | [no description available] | medium | 2 | 0 | 3-oxo steroid; aza-steroid; delta-lactam | androgen antagonist; antihyperplasia drug; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor |
sematilide | [no description available] | medium | 2 | 0 | | |
esmolol | [no description available] | medium | 1 | 0 | aromatic ether; ethanolamines; methyl ester; secondary alcohol; secondary amino compound | |
clinafloxacin | [no description available] | medium | 2 | 0 | quinolines | |
adefovir | [no description available] | medium | 2 | 0 | 6-aminopurines; ether; phosphonic acids | antiviral drug; DNA synthesis inhibitor; drug metabolite; HIV-1 reverse transcriptase inhibitor; nephrotoxic agent |
loxiglumide | [no description available] | medium | 2 | 0 | organic molecular entity | |
sparfloxacin | [no description available] | medium | 2 | 0 | fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | |
cidofovir anhydrous | [no description available] | medium | 2 | 0 | phosphonic acids; pyrimidone | anti-HIV agent; antineoplastic agent; antiviral drug; photosensitizing agent |
tiagabine | [no description available] | medium | 2 | 0 | beta-amino acid; piperidinemonocarboxylic acid; tertiary amino compound; thiophenes | anticonvulsant; GABA reuptake inhibitor |
mibefradil | [no description available] | medium | 1 | 0 | tetralins | T-type calcium channel blocker |
topotecan | [no description available] | medium | 1 | 0 | pyranoindolizinoquinoline | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor |
bromfenac | [no description available] | medium | 2 | 0 | aromatic amino acid; benzophenones; organobromine compound; substituted aniline | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
gemcitabine | [no description available] | medium | 1 | 0 | organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic |
ibutilide | [no description available] | medium | 1 | 0 | benzenes; organic amino compound | |
aripiprazole | [no description available] | medium | 1 | 0 | aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone | drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist |
remifentanil | [no description available] | medium | 1 | 0 | alpha-amino acid ester; anilide; monocarboxylic acid amide; piperidinecarboxylate ester | intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic; sedative |
lamivudine | [no description available] | medium | 2 | 0 | monothioacetal; nucleoside analogue; oxacycle; primary alcohol | allergen; anti-HBV agent; antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor; HIV-1 reverse transcriptase inhibitor; prodrug |
irinotecan | [no description available] | medium | 1 | 0 | carbamate ester; delta-lactone; N-acylpiperidine; pyranoindolizinoquinoline; ring assembly; tertiary alcohol; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug |
valsartan | [no description available] | medium | 2 | 0 | biphenylyltetrazole; monocarboxylic acid amide; monocarboxylic acid | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
ibandronic acid | [no description available] | medium | 1 | 0 | | |
ziprasidone | [no description available] | medium | 2 | 0 | 1,2-benzisothiazole; indolones; organochlorine compound; piperazines | antipsychotic agent; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; psychotropic drug; serotonergic antagonist |
zanamivir | [no description available] | medium | 2 | 0 | guanidines | antiviral agent; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor |
zolmitriptan | [no description available] | medium | 2 | 0 | oxazolidinone; tryptamines | anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
tirofiban | [no description available] | medium | 1 | 0 | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
cisatracurium | [no description available] | medium | 1 | 0 | diester; quaternary ammonium ion | muscle relaxant; nicotinic antagonist |
fosinoprilat | [no description available] | medium | 1 | 0 | L-proline derivative; phosphinic acids | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
trovafloxacin | [no description available] | medium | 2 | 0 | | |
cefprozil | [no description available] | medium | 1 | 0 | cephalosporin; semisynthetic derivative | antibacterial drug |
iopamidol | [no description available] | medium | 1 | 0 | benzenedicarboxamide; organoiodine compound; pentol | environmental contaminant; radioopaque medium; xenobiotic |
imipramine n-oxide | [no description available] | medium | 1 | 0 | dibenzooxazepine | |
dexloxiglumide | [no description available] | medium | 2 | 0 | glutamic acid derivative | |
intoplicine | [no description available] | medium | 1 | 0 | pyridoindole | |
repaglinide | [no description available] | medium | 2 | 0 | piperidines | |
telmisartan | [no description available] | medium | 2 | 0 | benzimidazoles; biphenyls; carboxybiphenyl | angiotensin receptor antagonist; antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; environmental contaminant; xenobiotic |
dexfenfluramine | [no description available] | medium | 1 | 0 | fenfluramine | appetite depressant; serotonergic agonist; serotonin uptake inhibitor |
ethinyl estradiol-17-sulfate | [no description available] | medium | 1 | 0 | | |
ethinylestradiol-3-sulfate | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; steroid sulfate | antineoplastic agent; estrogen |
cefcanel | [no description available] | medium | 2 | 0 | | |
zoledronic acid | [no description available] | medium | 1 | 0 | 1,1-bis(phosphonic acid); imidazoles | bone density conservation agent |
epristeride | [no description available] | medium | 2 | 0 | steroid acid | |
talinolol | [no description available] | medium | 2 | 0 | ureas | |
denaverine | [no description available] | medium | 1 | 0 | diarylmethane | |
diprafenone | [no description available] | medium | 1 | 0 | aromatic compound | |
nebivolol | [no description available] | medium | 1 | 0 | chromanes; diol; organofluorine compound; secondary alcohol; secondary amino compound | |
uk 68798 | [no description available] | medium | 2 | 0 | aromatic ether; sulfonamide; tertiary amino compound | anti-arrhythmia drug; potassium channel blocker |
ljc 10627 | [no description available] | medium | 1 | 0 | carbapenems; organic sulfide; pyrazolotriazole | antibacterial drug |
dexrazoxane | [no description available] | medium | 1 | 0 | razoxane | antineoplastic agent; cardiovascular drug; chelator; immunosuppressive agent |
voriconazole | [no description available] | medium | 1 | 0 | conazole antifungal drug; difluorobenzene; pyrimidines; tertiary alcohol; triazole antifungal drug | P450 inhibitor |
betamipron | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
bufuralol | [no description available] | medium | 2 | 0 | benzofurans | |
panipenem | [no description available] | medium | 1 | 0 | organic molecular entity | |
perindoprilat | [no description available] | medium | 1 | 0 | dicarboxylic acid; dipeptide; L-alanine derivative; organic heterobicyclic compound | antihypertensive agent; drug metabolite; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
7-hydroxystaurosporine | [no description available] | medium | 1 | 0 | | |
methotrimeprazine | [no description available] | medium | 2 | 0 | phenothiazines; tertiary amine | anticoronaviral agent; cholinergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; non-narcotic analgesic; phenothiazine antipsychotic drug; serotonergic antagonist |
9-aminocamptothecin | [no description available] | medium | 1 | 0 | pyranoindolizinoquinoline | |
sch 34343 | [no description available] | medium | 1 | 0 | | |
squalamine | [no description available] | medium | 1 | 0 | bile acid | |
atovaquone | [no description available] | medium | 2 | 0 | hydroxy-1,2-naphthoquinone | |
rivastigmine | [no description available] | medium | 1 | 0 | carbamate ester; tertiary amino compound | cholinergic drug; EC 3.1.1.8 (cholinesterase) inhibitor; neuroprotective agent |
frovatriptan | [no description available] | medium | 2 | 0 | carbazoles | |
eletriptan | [no description available] | medium | 1 | 0 | indoles; N-alkylpyrrolidine; sulfone | non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
rosiglitazone | [no description available] | medium | 2 | 0 | aminopyridine; thiazolidinediones | EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; insulin-sensitizing drug |
clarithromycin | [no description available] | medium | 2 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic |
nicotine | [no description available] | medium | 5 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic |
mci 9038 | [no description available] | medium | 1 | 0 | peptide | |
imipenem, anhydrous | [no description available] | medium | 2 | 0 | beta-lactam antibiotic allergen; carbapenems; zwitterion | antibacterial drug |
bosentan anhydrous | [no description available] | medium | 1 | 0 | primary alcohol; pyrimidines; sulfonamide | antihypertensive agent; endothelin receptor antagonist |
asulacrine | [no description available] | medium | 1 | 0 | acridines | |
hydroxycotinine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine; pyridines; pyrrolidin-2-ones; pyrrolidine alkaloid | |
quinaprilat | [no description available] | medium | 2 | 0 | dicarboxylic acid; isoquinolines; tertiary carboxamide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; vasodilator agent |
2-hydroxyimipramine | [no description available] | medium | 1 | 0 | dibenzoazepine | |
ecteinascidin 743 | [no description available] | medium | 1 | 0 | acetate ester; azaspiro compound; bridged compound; hemiaminal; isoquinoline alkaloid; lactone; organic heteropolycyclic compound; organic sulfide; oxaspiro compound; polyphenol; tertiary amino compound | alkylating agent; angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; marine metabolite |
almotriptan | [no description available] | medium | 1 | 0 | indoles; sulfonamide; tertiary amine | non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
mk 0663 | [no description available] | medium | 1 | 0 | bipyridines; organochlorine compound; sulfone | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
gefitinib | [no description available] | medium | 1 | 0 | aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist |
tamsulosin | [no description available] | medium | 2 | 0 | 5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide | alpha-adrenergic antagonist; antineoplastic agent |
sulbactam | [no description available] | medium | 1 | 0 | penicillanic acids | |
dilevalol | [no description available] | medium | 1 | 0 | 2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide | |
docetaxel | [no description available] | medium | 1 | 0 | hydrate; secondary alpha-hydroxy ketone | antineoplastic agent |
irofulven | [no description available] | medium | 1 | 0 | cyclohexenones | |
ym 872 | [no description available] | medium | 1 | 0 | | |
levofloxacin | [no description available] | medium | 2 | 0 | 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; fluoroquinolone antibiotic; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
ertapenem | [no description available] | medium | 1 | 0 | carbapenemcarboxylic acid; pyrrolidinecarboxamide | antibacterial drug |
dx 8951 | [no description available] | medium | 1 | 0 | pyranoindolizinoquinoline | |
cilomilast | [no description available] | medium | 2 | 0 | methoxybenzenes | |
conivaptan | [no description available] | medium | 2 | 0 | benzazepine | aquaretic; vasopressin receptor antagonist |
tezosentan | [no description available] | medium | 1 | 0 | | |
sabarubicin | [no description available] | medium | 1 | 0 | | |
moxifloxacin | [no description available] | medium | 2 | 0 | aromatic ether; cyclopropanes; fluoroquinolone antibiotic; pyrrolidinopiperidine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antibacterial drug |
clevidipine | [no description available] | medium | 1 | 0 | dihydropyridine | |
solifenacin | [no description available] | medium | 2 | 0 | isoquinolines | |
xamoterol | [no description available] | medium | 2 | 0 | morpholines | |
abanoquil | [no description available] | medium | 1 | 0 | | |
anidulafungin | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; azamacrocycle; echinocandin; heterodetic cyclic peptide; semisynthetic derivative | |
atropine | [no description available] | medium | 2 | 0 | | |
ropivacaine | [no description available] | medium | 1 | 0 | piperidinecarboxamide; ropivacaine | local anaesthetic |
melagatran | [no description available] | medium | 2 | 0 | azetidines; carboxamidine; dicarboxylic acid monoamide; non-proteinogenic alpha-amino acid; secondary amino compound | anticoagulant; EC 3.4.21.5 (thrombin) inhibitor; serine protease inhibitor |
tesaglitazar | [no description available] | medium | 2 | 0 | | |
bms204352 | [no description available] | medium | 1 | 0 | | |
fosfluconazole | [no description available] | medium | 1 | 0 | conazole antifungal drug; triazole antifungal drug; triazoles | prodrug |
cp 101,606 | [no description available] | medium | 1 | 0 | | |
nsc-89199 | [no description available] | medium | 2 | 0 | carbamate ester; organochlorine compound; steroid phosphate | |
phenethicillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | |
acivicin | [no description available] | medium | 1 | 0 | isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound | antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite |
bortezomib | [no description available] | medium | 1 | 0 | amino acid amide; L-phenylalanine derivative; pyrazines | antineoplastic agent; antiprotozoal drug; protease inhibitor; proteasome inhibitor |
quinidine | [no description available] | medium | 4 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
meropenem | [no description available] | medium | 1 | 0 | alpha,beta-unsaturated monocarboxylic acid; carbapenemcarboxylic acid; organic sulfide; pyrrolidinecarboxamide | antibacterial agent; antibacterial drug; drug allergen |
cefoxitin | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; cephalosporin; cephamycin; semisynthetic derivative | antibacterial drug |
digitoxin | [no description available] | medium | 1 | 0 | cardenolide glycoside | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor |
saquinavir | [no description available] | medium | 2 | 0 | L-asparagine derivative; quinolines | antiviral drug; HIV protease inhibitor |
pancuronium | [no description available] | medium | 1 | 0 | acetate ester; steroid ester | cholinergic antagonist; muscle relaxant; nicotinic antagonist |
rocuronium | [no description available] | medium | 1 | 0 | 3alpha-hydroxy steroid; acetate ester; androstane; morpholines; quaternary ammonium ion; tertiary amino compound | drug allergen; muscle relaxant; neuromuscular agent |
abacavir | [no description available] | medium | 1 | 0 | 2,6-diaminopurines | antiviral drug; drug allergen; HIV-1 reverse transcriptase inhibitor |
netilmicin | [no description available] | medium | 1 | 0 | | |
miglitol | [no description available] | medium | 2 | 0 | piperidines | |
linezolid | [no description available] | medium | 2 | 0 | acetamides; morpholines; organofluorine compound; oxazolidinone | antibacterial drug; protein synthesis inhibitor |
tolterodine | [no description available] | medium | 2 | 0 | tertiary amine | antispasmodic drug; muscarinic antagonist; muscle relaxant |
darifenacin | [no description available] | medium | 1 | 0 | 1-benzofurans; monocarboxylic acid amide; pyrrolidines | antispasmodic drug; muscarinic antagonist |
fluticasone propionate | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; corticosteroid; fluorinated steroid; propanoate ester; steroid ester; thioester | adrenergic agent; anti-allergic agent; anti-asthmatic drug; anti-inflammatory drug; bronchodilator agent; dermatologic drug |
acarbose | [no description available] | medium | 2 | 0 | amino cyclitol; glycoside | |
tacrolimus | [no description available] | medium | 2 | 0 | macrolide lactam | bacterial metabolite; immunosuppressive agent |
cerivastatin | [no description available] | medium | 2 | 0 | dihydroxy monocarboxylic acid; pyridines; statin (synthetic) | |
rosuvastatin | [no description available] | medium | 2 | 0 | dihydroxy monocarboxylic acid; monofluorobenzenes; pyrimidines; statin (synthetic); sulfonamide | anti-inflammatory agent; antilipemic drug; cardioprotective agent; CETP inhibitor; environmental contaminant; xenobiotic |
cocaine | [no description available] | medium | 1 | 0 | benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid | adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
clindamycin | [no description available] | medium | 2 | 0 | | |
fosfomycin | [no description available] | medium | 2 | 0 | epoxide; phosphonic acids | antimicrobial agent; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor |
zithromax | [no description available] | medium | 2 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; xenobiotic |
bms 214662 | [no description available] | medium | 1 | 0 | benzenes; benzodiazepine; imidazoles; nitrile; sulfonamide; thiophenes | antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor |
eptifibatide | [no description available] | medium | 1 | 0 | homodetic cyclic peptide; macrocycle; organic disulfide | anticoagulant; platelet aggregation inhibitor |
gs 4071 | [no description available] | medium | 2 | 0 | acetate ester; amino acid; cyclohexenecarboxylic acid; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; marine xenobiotic metabolite |
decitabine | [no description available] | medium | 1 | 0 | 2'-deoxyribonucleoside | |
sm 8668 | [no description available] | medium | 2 | 0 | | |
teniposide | [no description available] | medium | 1 | 0 | aromatic ether; beta-D-glucoside; cyclic acetal; furonaphthodioxole; gamma-lactone; monosaccharide derivative; phenols; thiophenes | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
troxacitabine | [no description available] | medium | 1 | 0 | carbohydrate derivative; nucleobase-containing molecular entity | |
cefamandole | [no description available] | medium | 1 | 0 | cephalosporin; semisynthetic derivative | antibacterial drug |
tiazofurin | [no description available] | medium | 1 | 0 | 1,3-thiazoles; C-glycosyl compound; monocarboxylic acid amide | antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; prodrug |
sitafloxacin | [no description available] | medium | 2 | 0 | fluoroquinolone antibiotic; quinolines; quinolone antibiotic | |
tenofovir | [no description available] | medium | 1 | 0 | nucleoside analogue; phosphonic acids | antiviral drug; drug metabolite; HIV-1 reverse transcriptase inhibitor |
dibekacin | [no description available] | medium | 1 | 0 | kanamycins | antibacterial agent; protein synthesis inhibitor |
micafungin | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; echinocandin | antiinfective agent |
mezlocillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug |
tropisetron | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
leuprolide | [no description available] | medium | 1 | 0 | oligopeptide | anti-estrogen; antineoplastic agent; gonadotropin releasing hormone agonist |
fludarabine | [no description available] | medium | 1 | 0 | purine nucleoside | |
propylthiouracil | [no description available] | medium | 2 | 0 | pyrimidinethione | antidote to paracetamol poisoning; antimetabolite; antioxidant; antithyroid drug; carcinogenic agent; EC 1.14.13.39 (nitric oxide synthase) inhibitor; hormone antagonist |
etomidate | [no description available] | medium | 1 | 0 | ethyl ester; imidazoles | intravenous anaesthetic; sedative |
mercaptopurine | [no description available] | medium | 1 | 0 | aryl thiol; purines; thiocarbonyl compound | anticoronaviral agent; antimetabolite; antineoplastic agent |
methimazole | [no description available] | medium | 1 | 0 | 1,3-dihydroimidazole-2-thiones | antithyroid drug |
drotaverin | [no description available] | medium | 2 | 0 | isoquinolines | |
digoxin | [no description available] | medium | 2 | 0 | cardenolide glycoside; steroid saponin | anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope |
cancidas | [no description available] | medium | 1 | 0 | | |
lincomycin | [no description available] | medium | 1 | 0 | carbohydrate-containing antibiotic; L-proline derivative; monocarboxylic acid amide; pyrrolidinecarboxamide; S-glycosyl compound | antimicrobial agent; bacterial metabolite |
thiopental | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic |
hmr 3647 | [no description available] | medium | 1 | 0 | | |
nelarabine | [no description available] | medium | 1 | 0 | beta-D-arabinoside; monosaccharide derivative; purine nucleoside | antineoplastic agent; DNA synthesis inhibitor; prodrug |
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine | [no description available] | medium | 2 | 0 | aromatic ether | |
dolasetron | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
or 1259 | [no description available] | medium | 1 | 0 | hydrazone; nitrile; pyridazinone | anti-arrhythmia drug; cardiotonic drug; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; vasodilator agent |
gestodene | [no description available] | medium | 1 | 0 | steroid | estrogen |
quinine | [no description available] | medium | 2 | 0 | cinchona alkaloid | antimalarial; muscle relaxant; non-narcotic analgesic |
isepamicin | [no description available] | medium | 1 | 0 | | |
ifetroban | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | |
lamifiban | [no description available] | medium | 1 | 0 | N-acylglycine | |
telavancin | [no description available] | medium | 1 | 0 | glycopeptide | antibacterial drug; antimicrobial agent |
sitagliptin | [no description available] | medium | 2 | 0 | triazolopyrazine; trifluorobenzene | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; environmental contaminant; hypoglycemic agent; serine proteinase inhibitor; xenobiotic |
tolcapone | [no description available] | medium | 1 | 0 | 2-nitrophenols; benzophenones; catechols | antiparkinson drug; EC 2.1.1.6 (catechol O-methyltransferase) inhibitor |
quercetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger |
clavulanic acid | [no description available] | medium | 2 | 0 | oxapenam | antibacterial drug; anxiolytic drug; bacterial metabolite; EC 3.5.2.6 (beta-lactamase) inhibitor |
eprosartan | [no description available] | medium | 2 | 0 | dicarboxylic acid; imidazoles; thiophenes | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
montelukast | [no description available] | medium | 2 | 0 | aliphatic sulfide; monocarboxylic acid; quinolines | anti-arrhythmia drug; anti-asthmatic drug; leukotriene antagonist |
mivacurium | [no description available] | medium | 1 | 0 | isoquinolines | |
entacapone | [no description available] | medium | 2 | 0 | 2-nitrophenols; catechols; monocarboxylic acid amide; nitrile | antidyskinesia agent; antiparkinson drug; central nervous system drug; EC 2.1.1.6 (catechol O-methyltransferase) inhibitor |
paricalcitol | [no description available] | medium | 2 | 0 | hydroxy seco-steroid; seco-cholestane | antiparathyroid drug |
sdz psc 833 | [no description available] | medium | 1 | 0 | homodetic cyclic peptide | |
indocyanine green | [no description available] | medium | 1 | 0 | 1,1-diunsubstituted alkanesulfonate; benzoindole; cyanine dye | |
codeine | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound | antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic |
hydromorphone | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound | mu-opioid receptor agonist; opioid analgesic |
nalmefene | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
naloxone | [no description available] | medium | 3 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
oxycodone | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound; semisynthetic derivative | antitussive; mu-opioid receptor agonist; opioid analgesic |
alvocidib | [no description available] | medium | 1 | 0 | dihydroxyflavone; hydroxypiperidine; monochlorobenzenes; tertiary amino compound | antineoplastic agent; antirheumatic drug; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
morphine | [no description available] | medium | 3 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
cicaprost | [no description available] | medium | 1 | 0 | monoterpenoid | |
dexmedetomidine | [no description available] | medium | 1 | 0 | medetomidine | alpha-adrenergic agonist; analgesic; non-narcotic analgesic; sedative |
iloprost | [no description available] | medium | 1 | 0 | carbobicyclic compound; monocarboxylic acid; secondary alcohol | platelet aggregation inhibitor; vasodilator agent |
nalbuphine | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound | mu-opioid receptor antagonist; opioid analgesic |
nateglinide | [no description available] | medium | 2 | 0 | phenylalanine derivative | |
vinorelbine | [no description available] | medium | 1 | 0 | acetate ester; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; ring assembly; vinca alkaloid | antineoplastic agent; photosensitizing agent |
romidepsin | [no description available] | medium | 1 | 0 | cyclodepsipeptide; heterocyclic antibiotic; organic disulfide | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | [no description available] | medium | 2 | 0 | dihydroxy monocarboxylic acid; indoles; organofluorine compound | |
naltrexone | [no description available] | medium | 1 | 0 | cyclopropanes; morphinane-like compound; organic heteropentacyclic compound | antidote to opioid poisoning; central nervous system depressant; environmental contaminant; mu-opioid receptor antagonist; xenobiotic |
morphine-6-glucuronide | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
butorphanol | [no description available] | medium | 1 | 0 | morphinane alkaloid | antitussive; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic |
cefodizime | [no description available] | medium | 1 | 0 | 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; EC 1.14.18.1 (tyrosinase) inhibitor |
methylnaltrexone | [no description available] | medium | 1 | 0 | phenanthrenes | |
cefixime | [no description available] | medium | 2 | 0 | cephalosporin | antibacterial drug; drug allergen |
lisinopril | [no description available] | medium | 2 | 0 | dipeptide | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
indinavir sulfate | [no description available] | medium | 1 | 0 | dicarboxylic acid diamide; N-(2-hydroxyethyl)piperazine; piperazinecarboxamide | HIV protease inhibitor |
enalaprilat anhydrous | [no description available] | medium | 2 | 0 | dicarboxylic acid; dipeptide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
cefuroxime | [no description available] | medium | 2 | 0 | 3-(carbamoyloxymethyl)cephalosporin; furans; oxime O-ether | drug allergen |
ceftriaxone | [no description available] | medium | 2 | 0 | 1,2,4-triazines; 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 3.5.2.6 (beta-lactamase) inhibitor |
cefepime | [no description available] | medium | 2 | 0 | cephalosporin; oxime O-ether | antibacterial drug |
hr 810 | [no description available] | medium | 1 | 0 | cephalosporin; cyclopentapyridine | |
ceftazidime | [no description available] | medium | 1 | 0 | cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor |
cefetamet | [no description available] | medium | 2 | 0 | cephalosporin | |
cefotaxime | [no description available] | medium | 1 | 0 | 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; drug allergen |
aztreonam | [no description available] | medium | 2 | 0 | beta-lactam antibiotic allergen; monobactam | antibacterial drug; drug allergen; EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor |
ginkgolide b | [no description available] | medium | 2 | 0 | | |
palonosetron | [no description available] | medium | 1 | 0 | azabicycloalkane; delta-lactam; organic heterotricyclic compound | antiemetic; serotonergic antagonist |
cefatrizine | [no description available] | medium | 2 | 0 | amino acid amide; carboxylic acid; cephalosporin; phenols; semisynthetic derivative; triazoles | antibacterial drug; EC 2.7.11.20 (elongation factor 2 kinase) inhibitor |
eniporide | [no description available] | medium | 1 | 0 | | |
cilastatin | [no description available] | medium | 1 | 0 | carboxamide; L-cysteine derivative; non-proteinogenic L-alpha-amino acid; organic sulfide | EC 3.4.13.19 (membrane dipeptidase) inhibitor; environmental contaminant; protease inhibitor; xenobiotic |
ixabepilone | [no description available] | medium | 1 | 0 | 1,3-thiazoles; beta-hydroxy ketone; epoxide; lactam; macrocycle | antineoplastic agent; microtubule-destabilising agent |
azlocillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin; semisynthetic derivative | antibacterial drug |
verlukast | [no description available] | medium | 1 | 0 | | |
ceftizoxime | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug |
carumonam | [no description available] | medium | 1 | 0 | monobactam | antibacterial drug |
nitrofurantoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione; nitrofuran antibiotic; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic | antibacterial drug; antiinfective agent; hepatotoxic agent |
eritoran | [no description available] | medium | 1 | 0 | lipid As | |
dantrolene | [no description available] | medium | 1 | 0 | | |
artesunate | [no description available] | medium | 1 | 0 | artemisinin derivative; cyclic acetal; dicarboxylic acid monoester; hemisuccinate; semisynthetic derivative; sesquiterpenoid | antimalarial; antineoplastic agent; ferroptosis inducer |
dexniguldipine | [no description available] | medium | 1 | 0 | diarylmethane | |
napsagatran | [no description available] | medium | 1 | 0 | | |
temsirolimus | [no description available] | medium | 1 | 0 | macrolide lactam | |
bms188797 | [no description available] | medium | 1 | 0 | | |
azimilide | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | |
tomopenem | [no description available] | medium | 1 | 0 | | |
bb-83698 | [no description available] | medium | 1 | 0 | | |
zotarolimus | [no description available] | medium | 1 | 0 | lactam; macrolide | |
gentamicin sulfate | [no description available] | medium | 2 | 0 | | |
bn 52020 | [no description available] | medium | 2 | 0 | | |
vindesine | [no description available] | medium | 1 | 0 | | |
bisaramil | [no description available] | medium | 1 | 0 | | |
teicoplanin | [no description available] | medium | 1 | 0 | | |
ly-146032 | [no description available] | medium | 1 | 0 | heterodetic cyclic peptide; lipopeptide antibiotic; lipopeptide; macrocycle; macrolide | antibacterial drug; bacterial metabolite; calcium-dependent antibiotics |
dalbavancin | [no description available] | medium | 1 | 0 | carbohydrate acid derivative; glycopeptide; monosaccharide derivative; semisynthetic derivative | antibacterial drug; antimicrobial agent |
cetrorelix | [no description available] | medium | 1 | 0 | oligopeptide | antineoplastic agent; GnRH antagonist |
tetracycline | [no description available] | medium | 2 | 0 | | |
chlortetracycline | [no description available] | medium | 1 | 0 | | |
oxytetracycline, anhydrous | [no description available] | medium | 1 | 0 | | |
minocycline | [no description available] | medium | 2 | 0 | | |
roquinimex | [no description available] | medium | 2 | 0 | aromatic amide | |
mobic | [no description available] | medium | 2 | 0 | 1,3-thiazoles; benzothiazine; monocarboxylic acid amide | analgesic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
mobiflex | [no description available] | medium | 2 | 0 | heteroaryl hydroxy compound; monocarboxylic acid amide; pyridines; thienothiazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
isoxicam | [no description available] | medium | 2 | 0 | benzothiazine; isoxazoles; monocarboxylic acid amide | antirheumatic drug; non-steroidal anti-inflammatory drug |
warfarin | [no description available] | medium | 2 | 0 | benzenes; hydroxycoumarin; methyl ketone | |
demeclocycline | [no description available] | medium | 1 | 0 | | |
rolitetracycline | [no description available] | medium | 1 | 0 | | |
tigecycline | [no description available] | medium | 1 | 0 | | |
rifampin | [no description available] | medium | 2 | 0 | cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion | angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor |
dacarbazine | [no description available] | medium | 1 | 0 | dacarbazine | |
didanosine | [no description available] | medium | 2 | 0 | purine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor; geroprotector; HIV-1 reverse transcriptase inhibitor |
sildenafil | [no description available] | medium | 2 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
penciclovir | [no description available] | medium | 2 | 0 | 2-aminopurines; propane-1,3-diols | antiviral drug |
vardenafil | [no description available] | medium | 2 | 0 | imidazotriazine; N-alkylpiperazine; N-sulfonylpiperazine | EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |
leucovorin | [no description available] | medium | 2 | 0 | formyltetrahydrofolic acid | Escherichia coli metabolite; mouse metabolite |
tegaserod | [no description available] | medium | 2 | 0 | carboxamidine; guanidines; hydrazines; indoles | gastrointestinal drug; serotonergic agonist |
tirapazamine | [no description available] | medium | 1 | 0 | aromatic amine; benzotriazines; N-oxide | antibacterial agent; antineoplastic agent; apoptosis inducer |
aprepitant | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; cyclic acetal; morpholines; triazoles | antidepressant; antiemetic; neurokinin-1 receptor antagonist; peripheral nervous system drug; substance P receptor antagonist |
ceftobiprole | [no description available] | medium | 1 | 0 | cephalosporin; thiadiazoles | antimicrobial agent |
rifabutin | [no description available] | medium | 2 | 0 | | |
astemizole | [no description available] | medium | 2 | 0 | benzimidazoles; piperidines | anti-allergic agent; anticoronaviral agent; H1-receptor antagonist |
aricine | [no description available] | medium | 2 | 0 | cinchona alkaloid | |
mefloquine hydrochloride | [no description available] | medium | 2 | 0 | organofluorine compound; piperidines; quinolines; secondary alcohol | |
n-acetyl-4-nitrophenylserinol | [no description available] | medium | 2 | 0 | | |
pronethalol | [no description available] | medium | 2 | 0 | naphthalenes | |
scriptaid | [no description available] | medium | 2 | 0 | isoquinolines | |
6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone | [no description available] | medium | 2 | 0 | cyclodepsipeptide | |
phanquinone | [no description available] | medium | 2 | 0 | orthoquinones | |
diphenan | [no description available] | medium | 2 | 0 | diarylmethane | |
2-phenylacetamide | [no description available] | medium | 2 | 0 | monocarboxylic acid amide | mouse metabolite |
tetraphenylborate | [no description available] | medium | 2 | 0 | | |
cycloguanil hydrochloride | [no description available] | medium | 2 | 0 | hydrochloride; organic molecular entity | |
emetine | [no description available] | medium | 2 | 0 | isoquinoline alkaloid; pyridoisoquinoline | antiamoebic agent; anticoronaviral agent; antiinfective agent; antimalarial; antineoplastic agent; antiprotozoal drug; antiviral agent; autophagy inhibitor; emetic; expectorant; plant metabolite; protein synthesis inhibitor |
gentian violet | [no description available] | medium | 1 | 0 | organic chloride salt | anthelminthic drug; antibacterial agent; antifungal agent; antiseptic drug; histological dye |
Berberine chloride (TN) | [no description available] | medium | 2 | 0 | organic molecular entity | |
9,10-dimethylanthracene | [no description available] | medium | 2 | 0 | | |
c 137 | [no description available] | medium | 2 | 0 | | |
buquinolate | [no description available] | medium | 2 | 0 | | |
propranolol glycol | [no description available] | medium | 2 | 0 | | |
thionine | [no description available] | medium | 1 | 0 | | |
neocuproine | [no description available] | medium | 2 | 0 | phenanthrolines | chelator; copper chelator |
mefloquine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
toxoflavin | [no description available] | medium | 2 | 0 | carbonyl compound; pyrimidotriazine | antibacterial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; toxin; virulence factor; Wnt signalling inhibitor |
selfotel | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid | |
2,2',2''-terpyridine | [no description available] | medium | 2 | 0 | terpyridines | chelator |
cletoquine | [no description available] | medium | 2 | 0 | | |
lycorine | [no description available] | medium | 2 | 0 | indolizidine alkaloid | anticoronaviral agent; antimalarial; plant metabolite; protein synthesis inhibitor |
bathophenanthroline | [no description available] | medium | 2 | 0 | benzenes; phenanthrolines | chelator |
fascaplysine | [no description available] | medium | 1 | 0 | | |
tryptanthrine | [no description available] | medium | 2 | 0 | alkaloid antibiotic; organic heterotetracyclic compound; organonitrogen heterocyclic compound | |
ethylhydrocupreine | [no description available] | medium | 2 | 0 | aromatic ether; cinchona alkaloid | EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
cinchonine | [no description available] | medium | 2 | 0 | (8xi)-cinchonan-9-ol; cinchona alkaloid | metabolite |
7-chloro-4-aminoquinoline | [no description available] | medium | 2 | 0 | aminoquinoline | |
mmv665852 | [no description available] | medium | 2 | 0 | | |
1,3,4,10-Tetrahydro-9(2H)-acridinone | [no description available] | medium | 2 | 0 | acridines | |
wr 158122 | [no description available] | medium | 2 | 0 | | |
dihydroergocristine | [no description available] | medium | 2 | 0 | ergot alkaloid | adrenergic antagonist; vasodilator agent |
cleistanthin b | [no description available] | medium | 2 | 0 | beta-D-glucoside; cleistanthins; monosaccharide derivative | alpha-adrenergic antagonist; antihypertensive agent; diuretic |
n-acetyltyramine | [no description available] | medium | 2 | 0 | acetamides; tyramines | animal metabolite; Aspergillus metabolite; bacterial metabolite; marine metabolite; quorum sensing inhibitor |
1,3-di(4-imidazolinophenoxyl)propane | [no description available] | medium | 2 | 0 | | |
7h-pyrido(4,3-c)carbazole | [no description available] | medium | 2 | 0 | | |
cl 246738 | [no description available] | medium | 2 | 0 | | |
celastrol methyl ester | [no description available] | medium | 2 | 0 | carboxylic ester | |
2-phenyl-4-oxohydroquinoline | [no description available] | medium | 2 | 0 | | |
cypripedin | [no description available] | medium | 2 | 0 | phenanthrol | |
respinomycin d | [no description available] | medium | 2 | 0 | | |
azacrin | [no description available] | medium | 1 | 0 | | |
acetoxycycloheximide | [no description available] | medium | 2 | 0 | | |
(R)-Roemerine | [no description available] | medium | 2 | 0 | isoquinoline alkaloid | |
anisomycin | [no description available] | medium | 1 | 0 | monohydroxypyrrolidine; organonitrogen heterocyclic antibiotic | anticoronaviral agent; antimicrobial agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; DNA synthesis inhibitor; protein synthesis inhibitor |
2-guanidine-4-methylquinazoline | [no description available] | medium | 2 | 0 | | |
jatrorrhizine chloride | [no description available] | medium | 1 | 0 | | |
puromycin | [no description available] | medium | 2 | 0 | puromycins | antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor |
trichostatin a | [no description available] | medium | 1 | 0 | antibiotic antifungal agent; hydroxamic acid; trichostatin | bacterial metabolite; EC 3.5.1.98 (histone deacetylase) inhibitor; geroprotector |
epothilone b | [no description available] | medium | 2 | 0 | epothilone; epoxide | antineoplastic agent; apoptosis inducer; microtubule-stabilising agent |
dactinomycin | [no description available] | medium | 2 | 0 | actinomycin | mutagen |
1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione | [no description available] | medium | 2 | 0 | pyrimidotriazine | |
jp-1302 | [no description available] | medium | 2 | 0 | | |
7-hydroxy-2-methoxy-1,4-phenanthrenedione | [no description available] | medium | 2 | 0 | | |
cgp 60474 | [no description available] | medium | 2 | 0 | substituted aniline | |
2-[2-hydroxy-6,7-dimethoxy-4-(4-morpholinyl)-1-naphthalenyl]-N-phenylacetamide | [no description available] | medium | 2 | 0 | naphthols | |
N4-(3-chlorophenyl)-6-methyl-N2-(phenylmethyl)pyrimidine-2,4-diamine | [no description available] | medium | 2 | 0 | aralkylamine | |
2,6-bis(benzimidazol-2-yl)pyridine | [no description available] | medium | 2 | 0 | benzimidazoles | |
n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 2 | 0 | | |
N-[4-(1-azepanyl)phenyl]-2-chloroacetamide | [no description available] | medium | 2 | 0 | anilide | |
N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester | [no description available] | medium | 2 | 0 | toluenes | |
(2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | [no description available] | medium | 2 | 0 | benzimidazoles | |
1,4,8-trimethyl-12-quinolino[2,3-b]quinolinamine | [no description available] | medium | 2 | 0 | aminoquinoline | |
2-furanyl-(4,4,8-trimethyl-1-sulfanylidene-5-dithiolo[3,4-c]quinolinyl)methanone | [no description available] | medium | 2 | 0 | aromatic amide; heteroarene | |
1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | medium | 2 | 0 | quinolines | |
stk295900 | [no description available] | medium | 2 | 0 | | |
6-(4-methyl-1-piperazinyl)-2-(3,4,5-trimethoxyphenyl)-1H-benzimidazole | [no description available] | medium | 2 | 0 | benzimidazoles | |
N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine | [no description available] | medium | 2 | 0 | aromatic ether | |
N-[2-[5-(1,3-benzothiazol-2-yl)-3-ethyl-1-phenyl-2-benzimidazol-3-iumyl]ethenyl]-N-methylaniline | [no description available] | medium | 2 | 0 | benzimidazoles | |
4-(1-adamantyl)-2-methyl-1,3-thiazole | [no description available] | medium | 2 | 0 | thiazoles | |
2-amino-6-[4-(6-chloro-2-pyridinyl)-1-piperazinyl]pyridine-3,5-dicarbonitrile | [no description available] | medium | 2 | 0 | piperazines; pyridines | |
1-(4-fluorophenyl)-3-[4-(4-fluorophenyl)-2-methyl-5-(trifluoromethyl)-3-pyrazolyl]urea | [no description available] | medium | 2 | 0 | pyrazoles; ring assembly | |
2-(4,6,7-Trimethyl-2-quinazolinyl)guanidine | [no description available] | medium | 2 | 0 | quinazolines | |
polysulfide rubber | [no description available] | medium | 2 | 0 | | |
4-(4-nitrophenyl)-N-prop-2-enyl-1-piperazinecarbothioamide | [no description available] | medium | 2 | 0 | piperazines | |
zd 6474 | [no description available] | medium | 2 | 0 | aromatic ether; organobromine compound; organofluorine compound; piperidines; quinazolines; secondary amine | antineoplastic agent; tyrosine kinase inhibitor |
5-bromo-1-(1-oxopropyl)-N,N-dipropyl-2,3-dihydroindole-7-sulfonamide | [no description available] | medium | 2 | 0 | indoles | |
N-cyclohexyl-5,6,7,8-tetrahydro-4H-cyclohepta[d]isoxazole-3-carboxamide | [no description available] | medium | 2 | 0 | aromatic amide; heteroarene | |
2-[(3-ethyl-7-methyl-4-oxo-6,8-dihydro-5H-pyrido[2,3]thieno[2,4-b]pyrimidin-2-yl)thio]-N-(2-phenylethyl)acetamide | [no description available] | medium | 2 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | |
trichomonacid | [no description available] | medium | 2 | 0 | | |
N-(4-bromo-3-methylphenyl)-2,5-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | [no description available] | medium | 2 | 0 | triazolopyrimidines | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-methoxyethyl)-3-oxo-1H-isoindole-4-carboxamide | [no description available] | medium | 2 | 0 | isoindoles | |
penicillin v | [no description available] | medium | 1 | 0 | 1,1'-diethyl-2,2'-cyanine; quinolines | |
hydrocortisone acetate, (11beta)-isomer | [no description available] | medium | 2 | 0 | | |
xib 4035 | [no description available] | medium | 2 | 0 | | |
10-hydroxy-3-methyl-8-pentyl-2,4-dihydro-1H-[1]benzopyrano[3,4-c]pyridin-5-one | [no description available] | medium | 2 | 0 | pyridochromene | |
lumefantrine | [no description available] | medium | 2 | 0 | fluorenes; monochlorobenzenes; secondary alcohol; tertiary amine | antimalarial |
suloctidil | [no description available] | medium | 1 | 0 | | |
edatrexate | [no description available] | medium | 2 | 0 | glutamic acid derivative | |
cgp 71683 a | [no description available] | medium | 1 | 0 | | |
artenimol | [no description available] | medium | 1 | 0 | | |
aee 788 | [no description available] | medium | 2 | 0 | 6-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist; trypanocidal drug |
tomaymycin | [no description available] | medium | 2 | 0 | tomaymycin | |
amodiaquine hydrochloride | [no description available] | medium | 1 | 0 | | |
gramicidin a | [no description available] | medium | 2 | 0 | | |
N-methyl-3-[5-(3-phenylpropyl)-1,3,4-oxadiazol-2-yl]-N-(3-thiophenylmethyl)propanamide | [no description available] | medium | 2 | 0 | benzenes | |
rs 39604 | [no description available] | medium | 1 | 0 | hydrochloride | serotonergic antagonist |
1-[amino-[(6-methoxy-4-methyl-2-quinazolinyl)amino]methylidene]-3-phenylurea | [no description available] | medium | 2 | 0 | quinazolines | |
dan 2163 | [no description available] | medium | 1 | 0 | aromatic amide; aromatic amine; benzamides; pyrrolidines; sulfone | environmental contaminant; second generation antipsychotic; xenobiotic |
practolol | [no description available] | medium | 1 | 0 | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist |
sulfasalazine | [no description available] | medium | 1 | 0 | | |
cloxacillin | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin; semisynthetic derivative | antibacterial agent; antibacterial drug |
ritonavir | [no description available] | medium | 1 | 0 | 1,3-thiazoles; carbamate ester; carboxamide; L-valine derivative; ureas | antiviral drug; environmental contaminant; HIV protease inhibitor; xenobiotic |
amphotericin b | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic | antiamoebic agent; antiprotozoal drug; bacterial metabolite |
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid | |
nsc-267703 | [no description available] | medium | 1 | 0 | anthracycline | |
dactinomycin | [no description available] | medium | 1 | 0 | cyclodepsipeptide | |
amodiaquine | [no description available] | medium | 1 | 0 | aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug |
berberine | [no description available] | medium | 1 | 0 | alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound | antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker |
clofilium | [no description available] | medium | 1 | 0 | benzenes; organic amino compound | |
dequalinium | [no description available] | medium | 1 | 0 | quinolinium ion | antifungal agent; antineoplastic agent; antiseptic drug; mitochondrial NADH:ubiquinone reductase inhibitor |
nsc-526417 | [no description available] | medium | 1 | 0 | | |
gentian violet | [no description available] | medium | 1 | 0 | iminium ion | antibacterial agent; antifungal agent |
hexahydrosiladifenidol | [no description available] | medium | 1 | 0 | | |
cycloguanil | [no description available] | medium | 1 | 0 | triazines | antifolate; antiinfective agent; antimalarial; antiparasitic agent; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor |
triphenyltetrazolium | [no description available] | medium | 1 | 0 | organic cation | |
berbamine | [no description available] | medium | 1 | 0 | phenylpropanoid | |
palmatine | [no description available] | medium | 1 | 0 | berberine alkaloid; organic heterotetracyclic compound | plant metabolite |
4,6-diamino-2,2-dimethyl-1,2-dihydro-1-phenyl-s-triazine | [no description available] | medium | 1 | 0 | | |
naphthoxybutanolcyclohexylamine | [no description available] | medium | 1 | 0 | | |
staurosporine | [no description available] | medium | 1 | 0 | indolocarbazole alkaloid; organic heterooctacyclic compound | apoptosis inducer; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; geroprotector |
propamidine | [no description available] | medium | 1 | 0 | aromatic ether; guanidines; polyether | antimicrobial agent; antiseptic drug |
quinocide | [no description available] | medium | 1 | 0 | | |
clobetasone butyrate | [no description available] | medium | 1 | 0 | organic molecular entity | |
jatrorrhizine | [no description available] | medium | 1 | 0 | alkaloid | |
LSM-4272 | [no description available] | medium | 1 | 0 | beta-carbolines | |
2,4-diamino-5,6-dihydro-6,6-dimethyl-5-(4'-methoxyphenyl)-s-triazine | [no description available] | medium | 1 | 0 | | |
10-deazaaminopterin | [no description available] | medium | 1 | 0 | | |
benzamil | [no description available] | medium | 1 | 0 | guanidines; pyrazines | |
imiloxan | [no description available] | medium | 1 | 0 | benzodioxine | |
epiberberine | [no description available] | medium | 1 | 0 | | |
mensacarcin | [no description available] | medium | 1 | 0 | | |
cephaelin | [no description available] | medium | 1 | 0 | pyridoisoquinoline | |
wr-142,490 | [no description available] | medium | 1 | 0 | [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol | antimalarial |
(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol | [no description available] | medium | 1 | 0 | alkylbenzene | |
n-(4-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 1 | 0 | | |
lch-7749944 | [no description available] | medium | 1 | 0 | | |
cgp 71683 a | [no description available] | medium | 1 | 0 | naphthalenes; sulfonic acid derivative | |
2-(dimethylaminostyryl)-1-ethylpyridinium | [no description available] | medium | 1 | 0 | pyridinium ion | |
norketotifen | [no description available] | medium | 1 | 0 | organosulfur heterocyclic compound | |
edaravone | [no description available] | medium | 1 | 0 | pyrazolone | antioxidant; radical scavenger |
propionic acid | [no description available] | medium | 1 | 0 | saturated fatty acid; short-chain fatty acid | antifungal drug |
nicergoline | [no description available] | medium | 1 | 1 | organic heterotetracyclic compound; organonitrogen heterocyclic compound | |
aluminum chloride | [no description available] | medium | 1 | 0 | aluminium coordination entity | Lewis acid |
malondialdehyde | [no description available] | medium | 1 | 0 | dialdehyde | biomarker |
glutamic acid | [no description available] | medium | 1 | 0 | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
calpain | [no description available] | medium | 1 | 0 | | |
palladium | [no description available] | medium | 1 | 0 | metal allergen; nickel group element atom; platinum group metal atom | |
congo red | [no description available] | medium | 1 | 0 | bis(azo) compound | |
acetonitrile | [no description available] | medium | 1 | 0 | aliphatic nitrile; volatile organic compound | EC 3.5.1.4 (amidase) inhibitor; NMR chemical shift reference compound; polar aprotic solvent |
dodecanol | [no description available] | medium | 1 | 0 | dodecanol; primary alcohol | bacterial metabolite; cosmetic; insect attractant; insecticide; pheromone; plant metabolite |
ethylbenzene | [no description available] | medium | 1 | 0 | alkylbenzene | |
benzene | [no description available] | medium | 1 | 0 | aromatic annulene; benzenes; volatile organic compound | carcinogenic agent; environmental contaminant; non-polar solvent |
cyclohexanol | [no description available] | medium | 1 | 0 | cyclohexanols; secondary alcohol | solvent |
trimethyltin | [no description available] | medium | 1 | 0 | | |
methylazoxymethanol acetate | [no description available] | medium | 1 | 0 | azoxy compound | |
dextroamphetamine | [no description available] | medium | 1 | 0 | 1-phenylpropan-2-amine | adrenergic agent; adrenergic uptake inhibitor; dopamine uptake inhibitor; dopaminergic agent; neurotoxin; sympathomimetic agent |
minaprine | [no description available] | medium | 1 | 0 | morpholines; pyridazines; secondary amine | antidepressant; antiparkinson drug; cholinergic drug; dopamine uptake inhibitor; serotonin uptake inhibitor |
ascorbic acid | [no description available] | medium | 1 | 0 | ascorbic acid; vitamin C | coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent |
glycine | [no description available] | medium | 2 | 0 | alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical |
idebenone | [no description available] | medium | 3 | 0 | 1,4-benzoquinones; primary alcohol | antioxidant; ferroptosis inhibitor |
ubiquinone | [no description available] | medium | 3 | 0 | | |
arecoline | [no description available] | medium | 1 | 0 | enoate ester; methyl ester; pyridine alkaloid; tetrahydropyridine | metabolite; muscarinic agonist |
cgp 36742 | [no description available] | medium | 2 | 0 | | |
glycerylphosphorylcholine | [no description available] | medium | 2 | 0 | glycerophosphocholine | |
pyrroles | [no description available] | medium | 1 | 0 | pyrrole; secondary amine | |
bmy 21502 | [no description available] | medium | 1 | 0 | | |
potassium cyanide | [no description available] | medium | 1 | 0 | cyanide salt; one-carbon compound; potassium salt | EC 1.15.1.1 (superoxide dismutase) inhibitor; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; neurotoxin |
cyclo(alanine-(1-amino-1-cyclopentane)carbonyl) | [no description available] | medium | 1 | 0 | | |
gyki 52466 | [no description available] | medium | 1 | 0 | benzodiazepine | |
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline | [no description available] | medium | 1 | 0 | naphthalenes; sulfonic acid derivative | |
quinoxalines | [no description available] | medium | 2 | 0 | mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene | |
bucladesine | [no description available] | medium | 1 | 0 | 3',5'-cyclic purine nucleotide | |
phosphocreatine | [no description available] | medium | 1 | 0 | phosphagen; phosphoamino acid | human metabolite; mouse metabolite |
valine | [no description available] | medium | 2 | 0 | L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
trandolapril | [no description available] | medium | 1 | 0 | dicarboxylic acid monoester; dipeptide; ethyl ester; organic heterobicyclic compound; secondary amino compound; tertiary carboxamide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug |
nefiracetam | [no description available] | medium | 2 | 0 | organonitrogen compound; organooxygen compound | |
indeloxazine | [no description available] | medium | 2 | 0 | indene | |
bifemelane | [no description available] | medium | 1 | 0 | diarylmethane | |
n-methylscopolamine | [no description available] | medium | 1 | 0 | | |
oxotremorine | [no description available] | medium | 2 | 0 | N-alkylpyrrolidine | |
secoverine | [no description available] | medium | 1 | 0 | | |
6-cyano-7-nitroquinoxaline-2,3-dione | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
4-anisic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid | plant metabolite |
pramiracetam | [no description available] | medium | 4 | 0 | organonitrogen compound; organooxygen compound | |
tranylcypromine | [no description available] | medium | 1 | 0 | 2-phenylcyclopropan-1-amine | |
cellulose | [no description available] | medium | 1 | 0 | glycoside | |
hemicholinium 3 | [no description available] | medium | 3 | 0 | | |
choline | [no description available] | medium | 7 | 0 | cholines | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite |
phosphatidylcholines | [no description available] | medium | 2 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
dihydroergotoxine | [no description available] | medium | 1 | 0 | | |
clobazam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator |
pyrrolidonecarboxylic acid | [no description available] | medium | 1 | 0 | 5-oxoproline; L-proline derivative; non-proteinogenic L-alpha-amino acid | algal metabolite |
ryodipine | [no description available] | medium | 1 | 0 | | |
enkephalin, leucine-2-alanine | [no description available] | medium | 1 | 0 | | |
mecamylamine | [no description available] | medium | 1 | 0 | primary aliphatic amine | |
glycerol | [no description available] | medium | 1 | 0 | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent |
n-acetylglycinamide | [no description available] | medium | 1 | 0 | | |
pyrithioxin | [no description available] | medium | 1 | 0 | methylpyridines | |
tyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
phenylalanine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
yohimbine | [no description available] | medium | 1 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | alpha-adrenergic antagonist; dopamine receptor D2 antagonist; serotonergic antagonist |
fipexide | [no description available] | medium | 1 | 0 | benzodioxoles | |
2-carboxyethyl gamma-aminobutyric acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
carcinine | [no description available] | low | 0 | 0 | beta-alanine derivative; imidazoles; monocarboxylic acid amide; organonitrogen compound; organooxygen compound | antioxidant; crustacean metabolite |
dimethyl pyrocarbonate | [no description available] | low | 0 | 0 | organooxygen compound | |
methoxyamine | [no description available] | low | 0 | 0 | organooxygen compound | |
etozolin | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-acetyltributylcitrate | [no description available] | low | 0 | 0 | organooxygen compound | |
guanidine carboxamide | [no description available] | low | 0 | 0 | organooxygen compound | |
cuprizone | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
cdta | [no description available] | low | 0 | 0 | organooxygen compound | |
alpha-fluoro-beta-alanine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
ammonium bicarbonate | [no description available] | low | 0 | 0 | organooxygen compound | |
4-amino-3-phenylbutyric acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
zinc carbonate | [no description available] | low | 0 | 0 | organooxygen compound | |
nicofuranose | [no description available] | low | 0 | 0 | organooxygen compound | |
lodoxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
Arbaclofen | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
etiracetam | [no description available] | low | 0 | 0 | organooxygen compound | |
azidoamphenicol | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
telmesteine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
pivagabine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-carboxythiazolidine-4-carboxylic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
alpha-lapachone | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
5,5-dimethylthiazolidine-4-carboxylic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
aurofusarin | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylic acid tetramethyl ester | [no description available] | low | 0 | 0 | organooxygen compound | |
n-nitrosothiazolidine-4-carboxylic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
pyridinoline | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
paspaline | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
2-methyl-5-nitroimidazol-1-ylacetic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-carboxymethyl-6-benzyl-2,5-diketopiperazine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3,5-diiodothyronine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
salvinorin a | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | metabolite; oneirogen |
merodantoin | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
sch 45752 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
argininic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
delta-guanidinovaleric acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
chlorocarbonic acid | [no description available] | low | 0 | 0 | organooxygen compound | |
byssochlamic acid | [no description available] | low | 0 | 0 | organooxygen compound | |
mirestrol | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
isoputreanine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
cyclo(glycylprolyl) | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
cyclo(tyrosyl-prolyl) | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
columbin | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-cyclopropyl-N-[2-[(4-methoxyphenyl)methylamino]-2-oxo-1-thiophen-2-ylethyl]-4-thiadiazolecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(cyclopentylamino)-1-(5-methyl-2-furanyl)-2-oxoethyl]-N-[(4-fluorophenyl)methyl]-4-thiadiazolecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(cyclohexylamino)-1-(2-furanyl)-2-oxoethyl]-N-(2-furanylmethyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-butan-2-yl-N-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-4-thiadiazolecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N'-[2-(cyclohexylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)-N'-phenylpentanediamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-N-cyclohexyl-2-furancarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(N-[2-(1-benzotriazolyl)-1-oxoethyl]-4-methoxyanilino)-N-(2-methylbutan-2-yl)-2-(1-methyl-2-pyrrolyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(N-[2-(1-benzotriazolyl)-1-oxoethyl]-4-methylanilino)-N-(2-furanylmethyl)-2-(3-pyridinyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]-N-cyclopropyl-4-thiadiazolecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-cyclopentyl-2-[2-oxolanylmethyl-(1-oxo-2-thiophen-2-ylethyl)amino]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N'-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-N'-(3-fluorophenyl)-N-(3-pyridinyl)butanediamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(2,4-dioxo-3-thiazolidinyl)-N-(2,3,4-trifluorophenyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-tert-butyl-2-(2-furanyl)-2-[[2-[5-(5-methyl-2-furanyl)-2-tetrazolyl]-1-oxoethyl]-(thiophen-2-ylmethyl)amino]acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N'-[1-[(cyclohexylamino)-oxomethyl]cyclopentyl]-N-(5-methyl-3-isoxazolyl)-N'-phenylbutanediamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-propan-2-ylamino]-2-(2,5-dimethoxyphenyl)-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(2-furanylmethyl)amino]-N-cyclohexyl-2-(2-fluorophenyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N'-[2-(cyclopentylamino)-2-oxoethyl]-N'-(3,4-dimethylphenyl)-N-(2-pyridinyl)pentanediamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(1,3-benzodioxol-5-yl)-N-[1-(4-chlorophenyl)-2-(cyclohexylamino)-2-oxoethyl]-2-pyrazinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[(3-methyl-2,4-dioxo-5-thiazolidinyl)amino]benzoic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-amino-N5-[2-(2-methoxyethylamino)-1-(5-methyl-2-furanyl)-2-oxoethyl]-N5-(thiophen-2-ylmethyl)isothiazole-3,5-dicarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N'-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-N-(5-methyl-3-isoxazolyl)-N'-phenylbutanediamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[1,3-benzodioxol-5-yl-[2-(1-benzotriazolyl)-1-oxoethyl]amino]-N-(2-methoxyethyl)-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-[2-[cyano-(4,6-dimethyl-2-pyrimidinyl)amino]-1-oxoethyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-[3-(4-methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-[[(5-bromo-3-pyridinyl)-oxomethyl]amino]propanoic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(2,4-dimethoxyphenyl)-3-(4-morpholinyl)propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-[[2-(3-methylanilino)-1-oxoethyl]amino]-3-phenylthiourea | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-oxo-3-benzo[h][1]benzopyrancarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
1-(2,3-dimethyl-1-indolyl)-2-(4-methyl-1-piperidinyl)ethanone | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-(N-[2-(Benzotriazol-1-yl)acetyl]-4-methoxyanilino)-N-cyclopentylcyclohexane-1-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | anticoronaviral agent |
4-(4-methylphenyl)-2-[[3-(4-morpholinyl)-1-oxopropyl]amino]-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-imino-2-benzo[f][1]benzopyrancarbothioamide | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
3-(3-oxo-2-benzo[f][1]benzopyranyl)-1-phenyl-4-pyrazolecarboxaldehyde | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
2-[(4-fluorophenyl)hydrazo]-2-oxoacetic acid ethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-[(3,5-dimethylphenyl)-oxomethyl]-1,3-dihydroquinoxalin-2-one | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(3,5-dimethoxyphenyl)-2-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
5-[(2-chlorophenyl)hydrazo]-3,3-bis(hydroxymethyl)-2H-1,4-oxazin-6-one | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[(3-acetyl-5-oxo-4H-imidazol-2-yl)thio]-N-(4-methyl-5-phenyl-2-thiazolyl)-N-prop-2-enylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[(3-acetyl-5-oxo-4H-imidazol-2-yl)thio]-N-(4,5-diphenyl-2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-chloro-N-[3-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-oxopropyl]benzamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-bromo-N-[3-oxo-3-(2-thiazolylamino)propyl]benzamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[3-[4-[(2-methoxyphenyl)sulfamoyl]anilino]-3-oxopropyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-(4-Chloroanilino)propanoic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1,4-dihydroxy-4a,5,6,7,8,8a-hexahydroquinoxaline-2,3-dione | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(2-furanyl)-4-thiazolidinecarboxylic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
methyl-thiohydantoin-tryptophan | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(difluoromethyl)-4-benzo[h][1]benzopyranone | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
3-hydroxy-7-methyl-3-(4-morpholinyl)-5-nitro-1H-indol-2-one | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
5-bromo-3-hydroxy-3-(4-methyl-1-piperidinyl)-1H-indol-2-one | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(3,4-dimethylphenyl)-2-(4-methylanilino)-6-oxo-4,5-dihydro-1H-pyrimidine-4-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(3-chloro-4-methylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(1-azepanyl)-2-oxoethyl]-N-[(4-chlorophenyl)methyl]methanesulfonamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[1-[[[(3-chloro-1-benzothiophen-2-yl)-oxomethyl]amino]-sulfanylidenemethyl]-3-oxo-2-piperazinyl]acetic acid methyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(2-methoxy-2-oxoethyl)-3-oxo-1-piperazinecarboxylic acid tert-butyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
albutoin | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-thioxo-4-thiazolidinecarboxylic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
momilactone b | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-[[2-(4-chlorophenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-methyl-2-[3-methyl-4-(3-methylphenyl)azo-5-oxo-4H-pyrazol-1-yl]-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
5'-(4-methylphenyl)-2-spiro[1H-indole-3,2'-3H-1,3,4-thiadiazole]one | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(cyclopentylamino)-1-(4-fluorophenyl)-2-oxoethyl]-N-[(4-fluorophenyl)methyl]-1H-pyrazole-5-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(cyclopentylamino)-1-(3,4-dimethoxyphenyl)-2-oxoethyl]-N-[(4-fluorophenyl)methyl]-1H-pyrazole-5-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
uccf-029 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
2-(2-furanyl)-2-[(4-methoxyphenyl)methyl-[2-[5-(5-methyl-2-furanyl)-2-tetrazolyl]-1-oxoethyl]amino]-N-(2-oxolanylmethyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[cyclopentyl-[1-oxo-2-(5-thiophen-2-yl-2-tetrazolyl)ethyl]amino]-N-(2-oxolanylmethyl)-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(N-[2-(Benzotriazol-1-yl)acetyl]-2,4,6-trimethylanilino)-N-tert-butyl-2-thiophen-3-ylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | anticoronaviral agent |
CID 3206295 | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | anticoronaviral agent |
N-tert-butyl-2-[(2-chloro-1-oxoethyl)-(2-furanylmethyl)amino]-2-(4-chlorophenyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N'-(1,3-benzodioxol-5-ylmethyl)-N'-[2-(cyclopentylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)butanediamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(3-pyridinyl)amino]-2-(4-chlorophenyl)-N-(2-methoxyethyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-cyclohexyl-2-(4-fluoro-N-[1-oxo-2-(3-thiophenyl)ethyl]anilino)-2-(4-fluorophenyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-(2-methyl-2,3-dihydroindol-1-yl)-2-[4-[5-(trifluoromethyl)-1-benzotriazolyl]-1-piperidinyl]ethanone | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
5-bromo-N-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]-N-methyl-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-cyclopentyl-3-[(4-methylphenyl)sulfonylamino]propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[(5-bromo-2-thiophenyl)sulfonyl-methylamino]-N-(6-methyl-1,3-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-[(4-methoxyphenyl)sulfonylamino]-N-(phenylmethyl)propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(4-methyl-1-oxo-[1]benzothiolo[2,3-d]pyridazin-2-yl)propanoic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-amino-4-(1,3-benzothiazol-2-yl)-N-(3-chloro-2-methylphenyl)-5-phenylimino-2H-thiophene-2-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
6-amino-5-cyano-4-(2-fluorophenyl)-2-sulfanylidene-3,4-dihydro-1H-pyridine-3-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(5-chloro-2-methoxyphenyl)-2-pyridin-4-yl-4,5-dihydrothiazole-4-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(N-(2-chloro-1-oxoethyl)-3-methoxyanilino)-N-(2-phenylethyl)-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(N-(2-chloro-1-oxoethyl)-4-methoxyanilino)-N-(2-phenylethyl)-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
LSM-1924 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
LSM-16912 | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(4-phenylmethoxyphenyl)-3-[4-(phenylmethyl)-1-piperazinyl]propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3,6-bis[(1H-indol-3-yl)methyl]piperazine-2,5-dione | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
LSM-22738 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-[1-(cyclopentylamino)-2-methyl-1-oxobutan-2-yl]-N-(thiophen-2-ylmethyl)-2-pyridinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(2-furanylmethyl)-2-pyridinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[1-(cyclohexylamino)-2-methyl-1-oxobutan-2-yl]-N-(2-furanylmethyl)-2-pyridinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[6-amino-2,4-dioxo-1-(phenylmethyl)-5-pyrimidinyl]-N-ethyl-2-(2-methyl-2,3-dihydroindol-1-yl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(thiophen-2-ylmethyl)-2-pyrazinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-[2-(4-methoxyphenyl)-4-[oxo(1-pyrrolidinyl)methyl]-3-thiazolidinyl]-1-propanone | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
LSM-26445 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
2-(N-(2-chloro-1-oxoethyl)-4-fluoroanilino)-N-cyclohexyl-2-(3-pyridinyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(N-(2-chloro-1-oxoethyl)-4-methoxyanilino)-N-cyclohexyl-2-(3-pyridinyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(3-chloro-N-(2-chloro-1-oxoethyl)anilino)-N-cyclohexyl-2-(3-pyridinyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(2,3-dioxo-1-indolyl)-N-(2-phenylethyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[5-(phenylmethyl)-2-thiazolyl]-4,5-dihydro-1H-imidazole-2-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
LSM-1925 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
2-[[(3-amino-4-carbamoyl-5-cyclohexylimino-2H-thiophen-2-yl)-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-amino-N2-(2,3-dichlorophenyl)-5-(2-methoxyphenyl)imino-2H-thiophene-2,4-dicarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
5'-bromo-2'-spiro[1,2-dihydro-4,1,2-benzoxadiazine-3,3'-1H-indole]one | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
LSM-25964 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-(5,5-dimethyl-7-oxo-4,6-dihydro-1,3-benzothiazol-2-yl)-2-(2,5-dioxo-1-pyrrolidinyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(thiophen-2-ylmethyl)-2-pyridinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
chicoric acid | [no description available] | low | 0 | 0 | organooxygen compound | geroprotector; HIV-1 integrase inhibitor |
1-[2-(4-morpholinyl)-2-oxoethyl]-2-pyrido[2,3-b][1,4]thiazinone | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
aurantiamine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
5-aminolevulinic acid hexyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
gabalid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
tremortin a | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-[3-[(1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)methylamino]-3-oxopropyl]-3-methoxybenzamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
4-chloro-N-[4-[3-(methylthio)anilino]-4-oxobutyl]benzamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(2,6-dichloroanilino)-2-oxoethyl]-N-methyl-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[2-(4-chlorophenyl)ethyl]-2-[3-[(2-fluorophenyl)methyl]-2-oxo-1-imidazolidinyl]acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[3-[(2-chloro-4-fluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl]-N-cyclooctylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
nu 7026 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
seletracetam | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
terpendole e | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
elagolix | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
citrinadin a | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
moiramide b | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[(1,3-dioxo-2-phenyl-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl)methyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
lc15-0444 | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(3-chloro-N-(2-chloro-1-oxoethyl)anilino)-N-cyclohexyl-2-(4-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-(4-chloro-N-(2-chloro-1-oxoethyl)anilino)-N-cyclohexyl-2-(4-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
2-[(2-chloro-1-oxoethyl)-(2,2-dimethoxyethyl)amino]-2-(4-chlorophenyl)-N-cyclohexylacetamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-(4-fluorophenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-(4-methylphenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
1-(3-chlorophenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]-4-phenyl-1-piperazinecarbothioamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-acetamido-N-[4-(4-methylsulfonylphenyl)-2-thiazolyl]-3-phenyl-N-prop-2-enylpropanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
thallusin | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
3-[4-[2-(2-fluorophenyl)ethylamino]-3-nitrophenyl]-3-[[2-(1-naphthalenyl)-1-oxoethyl]amino]propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
aflatrem | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
N-[(2-ethoxyphenyl)methyl]-3-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
(3S)-3-(2-methylpropyl)-4-oxo-3-phenyldiazetidine-1,2-dicarboxylic acid dimethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
(3S)-3-(4-methoxyphenyl)-4-oxo-3-propan-2-yldiazetidine-1,2-dicarboxylic acid dimethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
(3S)-4-oxo-3-phenyl-3-propan-2-yldiazetidine-1,2-dicarboxylic acid dimethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
(3S)-3-cyclopentyl-4-oxo-3-phenyldiazetidine-1,2-dicarboxylic acid dimethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
(3R)-3-(4-chlorophenyl)-4-oxo-3-propan-2-yldiazetidine-1,2-dicarboxylic acid diethyl ester | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
LSM-1873 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
LSM-1834 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
LSM-1287 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
LSM-1675 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
LSM-1312 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
LSM-1315 | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
gsk 1838705a | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-(4-fluorophenylethylamino)-1-methyl-4-(2-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dione | [no description available] | low | 0 | 0 | maleimides; organonitrogen compound; organooxygen compound | |
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
neosurugatoxin | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
3-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
putreanine | [no description available] | low | 0 | 0 | carboxylic acid anion; N-substituted putrescine; organonitrogen compound; organooxygen compound | |
santacruzamate a | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
8-epidiosbulbin e acetate | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
2-[(2-oxo-3-indolyl)amino]-N-(2-phenylethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
pterine-6-carboxylic acid | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
conocurvone | [no description available] | low | 0 | 0 | organic heterotricyclic compound; organooxygen compound | |
phosphocreatinine | [no description available] | low | 0 | 0 | organonitrogen compound; organooxygen compound | |
carbamic acid | [no description available] | low | 0 | 0 | carbon oxoacid; one-carbon compound; organonitrogen compound | Escherichia coli metabolite |
1,6-bis(cyclohexyloximinocarbonyl)hexane | [no description available] | low | 0 | 0 | carbamate ester; organonitrogen compound | |
tetranitromethane | [no description available] | low | 0 | 0 | organonitrogen compound | |
methyl 4-mercaptobutyrimidate | [no description available] | low | 0 | 0 | organonitrogen compound; oxoacid derivative | |
N,N-dimethylcarbamodithioic acid (1-acetamido-2,2,2-trichloroethyl) ester | [no description available] | low | 0 | 0 | organonitrogen compound; organosulfur compound | |
N,N-diethylcarbamodithioic acid (2,2,2-trichloro-1-formamidoethyl) ester | [no description available] | low | 0 | 0 | organonitrogen compound; organosulfur compound | |
n,n',n''-triacetylfusarinine c | [no description available] | low | 0 | 0 | iron coordination entity; organonitrogen compound | |
curacin d | [no description available] | low | 0 | 0 | heterocyclic compound; organonitrogen compound; organosulfur compound | |